<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">29304140</article-id><article-id pub-id-type="pmc">5755747</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0189176</article-id><article-id pub-id-type="publisher-id">PONE-D-16-40579</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Edema</subject><subj-group><subject>Lymphedema</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pathology and Laboratory Medicine</subject><subj-group><subject>Signs and Symptoms</subject><subj-group><subject>Edema</subject><subj-group><subject>Lymphedema</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Surgical and Invasive Medical Procedures</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Diagnostic Medicine</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Lymphoscintigraphy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Imaging Techniques</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Lymphoscintigraphy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Radiology and Imaging</subject><subj-group><subject>Diagnostic Radiology</subject><subj-group><subject>Lymphoscintigraphy</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancers and Neoplasms</subject><subj-group><subject>Breast Tumors</subject><subj-group><subject>Breast Cancer</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic System</subject><subj-group><subject>Lymph Nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Lymphatic System</subject><subj-group><subject>Lymph Nodes</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Cancer Treatment</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Clinical Medicine</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Oncology</subject><subj-group><subject>Clinical Oncology</subject><subj-group><subject>Surgical Oncology</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Public and Occupational Health</subject><subj-group><subject>Physical Activity</subject><subj-group><subject>Physical Fitness</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Sports Science</subject><subj-group><subject>Sports and Exercise Medicine</subject><subj-group><subject>Exercise</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Lymph</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Lymph</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Lymph</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body Fluids</subject><subj-group><subject>Lymph</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>Long term effects of manual lymphatic drainage and active exercises on physical morbidities, lymphoscintigraphy parameters and lymphedema formation in patients operated due to breast cancer: A clinical trial</article-title><alt-title alt-title-type="running-head">Long-term effects of physiotherapy techniques on physical morbidity postoperative breast cancer</alt-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6910-9387</contrib-id><name><surname>de Oliveira</surname><given-names>Mariana Maia Freire</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Gurgel</surname><given-names>Maria Salete Costa</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Amorim</surname><given-names>B&#x000e1;rbara Juarez</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ramos</surname><given-names>Celso Dario</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Project administration</role><role content-type="http://credit.casrai.org/">Supervision</role><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author"><name><surname>Derchain</surname><given-names>Sophie</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Furlan-Santos</surname><given-names>Natachie</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>dos Santos</surname><given-names>C&#x000e9;sar Cabello</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Data curation</role><role content-type="http://credit.casrai.org/">Investigation</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="author-notes" rid="econtrib001"><sup>&#x02021;</sup></xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Sarian</surname><given-names>Lu&#x000ed;s Ot&#x000e1;vio</given-names></name><role content-type="http://credit.casrai.org/">Conceptualization</role><role content-type="http://credit.casrai.org/">Formal analysis</role><role content-type="http://credit.casrai.org/">Funding acquisition</role><role content-type="http://credit.casrai.org/">Methodology</role><role content-type="http://credit.casrai.org/">Resources</role><role content-type="http://credit.casrai.org/">Supervision</role><role content-type="http://credit.casrai.org/">Validation</role><role content-type="http://credit.casrai.org/">Visualization</role><role content-type="http://credit.casrai.org/">Writing &#x02013; original draft</role><role content-type="http://credit.casrai.org/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>Department of Obstetrics and Gynecology- University of Campinas, School of Medicine, Campinas, S&#x000e3;o Paulo, Brazil</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Department of Nuclear Medicine and Radiology, University of Campinas, School of Medicine, Campinas, S&#x000e3;o Paulo, Brazil</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Taradaj</surname><given-names>Jakub</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>Academy School of Physical Education, POLAND</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="econtrib001"><p>&#x02021; These authors also contributed equally to this work.</p></fn><corresp id="cor001">* E-mail: <email>marimfo@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub"><day>5</day><month>1</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>13</volume><issue>1</issue><elocation-id>e0189176</elocation-id><history><date date-type="received"><day>28</day><month>11</month><year>2016</year></date><date date-type="accepted"><day>15</day><month>11</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2018 Oliveira et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Oliveira et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0189176.pdf"/><abstract><sec id="sec001"><title>Purpose</title><p>evaluate whether manual lymphatic drainage (MLD) or active exercise (AE) is associated with shoulder range of motion (ROM), wound complication and changes in the lymphatic parameters after breast cancer (BC) surgery and whether these parameters have an association with lymphedema formation in the long run.</p></sec><sec id="sec002"><title>Methods</title><p>Clinical trial with 106 women undergoing radical BC surgery, in the Women&#x02019;s Integrated Healthcare Center&#x02014;University of Campinas. Women were matched for staging, age and body mass index and were allocated to performed AE or MLD, 2 weekly sessions during one month after surgery. The wound was evaluated 2 months after surgery. ROM, upper limb circumference measurement and upper limb lymphoscintigraphy were performed before surgery, and 2 and 30 months after surgery.</p></sec><sec id="sec003"><title>Results</title><p>The incidence of seroma, dehiscence and infection did not differ between groups. Both groups showed ROM deficit of flexion and abduction in the second month postoperative and partial recovery after 30 months. Cumulative incidence of lymphedema was 23.8% and did not differ between groups (p = 0.29). Concerning the lymphoscintigraphy parameters, there was a significant convergent trend between baseline degree uptake (p = 0.003) and velocity visualization of axillary lymph nodes (p = 0.001) with lymphedema formation. A reduced marker uptake before or after surgery predicted lymphedema formation in the long run (&#x0003e;2 years). None of the lymphoscintigraphy parameters were shown to be associated with the study group. Age &#x02264;39 years was the factor with the greatest association with lymphedema (p = 0.009). In women with age &#x02264;39 years, BMI &#x0003e;24Kg/m<sup>2</sup> was significantly associated with lymphedema (p = 0.017). In women over 39 years old, women treated with MLD were at a significantly higher risk of developing lymphedema (p = 0.011).</p></sec><sec id="sec004"><title>Conclusion</title><p>Lymphatic abnormalities precede lymphedema formation in BC patients. In younger women, obesity seems to be the major player in lymphedema development and, in older women, improving muscle strength through AE can prevent lymphedema. In essence, MLD is as safe and effective as AE in rehabilitation after breast cancer surgery.</p></sec></abstract><funding-group><award-group id="award001"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</institution></institution-wrap></funding-source><award-id>2009/14864-1</award-id><principal-award-recipient><name><surname>Gurgel</surname><given-names>Maria Salete Costa</given-names></name></principal-award-recipient></award-group><award-group id="award002"><funding-source><institution-wrap><institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100001807</institution-id><institution>Funda&#x000e7;&#x000e3;o de Amparo &#x000e0; Pesquisa do Estado de S&#x000e3;o Paulo</institution></institution-wrap></funding-source><award-id>2014/14190-9</award-id><principal-award-recipient><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-6910-9387</contrib-id><name><surname>de Oliveira</surname><given-names>Mariana Maia Freire</given-names></name></principal-award-recipient></award-group><funding-statement>This work was supported by the S&#x000e3;o Paulo Research Foundation (FAPESP): 2009/14864-1 (MSCG) and 2014/14190-9 (MMFO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><fig-count count="3"/><table-count count="5"/><page-count count="18"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>All relevant data are within the paper and its Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>All relevant data are within the paper and its Supporting Information files.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Early diagnosis and treatment advances in breast cancer (BC) allowed increased survival [<xref rid="pone.0189176.ref001" ref-type="bibr">1</xref>], so that more women are living with possible side effects of the treatment [<xref rid="pone.0189176.ref002" ref-type="bibr">2</xref>]. Morbidities in the upper limb (UL) ipsilateral to surgery are among the main adverse effects of treatment. One year after surgery, approximately 85% [<xref rid="pone.0189176.ref003" ref-type="bibr">3</xref>] of the women report at least one physical morbidity, such as pain, limited range of motion (ROM), and lymphedema [<xref rid="pone.0189176.ref004" ref-type="bibr">4</xref>]. Therefore, there is an effort to implement preventive measures and treatments to minimize these considerable functional and psychological disturbances [<xref rid="pone.0189176.ref005" ref-type="bibr">5</xref>&#x02013;<xref rid="pone.0189176.ref007" ref-type="bibr">7</xref>].</p><p>Breast cancer related lymphedema is one of the most common physical complications causing substantial functional and psychological disturbance [<xref rid="pone.0189176.ref006" ref-type="bibr">6</xref>,<xref rid="pone.0189176.ref007" ref-type="bibr">7</xref>, <xref rid="pone.0189176.ref008" ref-type="bibr">8</xref>]. It is a chronic condition that may develop any time after surgery [<xref rid="pone.0189176.ref009" ref-type="bibr">9</xref>]. Recently, questions regarding the role of exercise and the risk of lymphedema have emerged [<xref rid="pone.0189176.ref010" ref-type="bibr">10</xref>]. The benefits of active exercise (AE) in shoulder rehabilitation after breast cancer surgery are extensively described in the literature [<xref rid="pone.0189176.ref011" ref-type="bibr">11</xref>&#x02013;<xref rid="pone.0189176.ref014" ref-type="bibr">14</xref>], and this approach has become standard practice in referral services [<xref rid="pone.0189176.ref009" ref-type="bibr">9</xref>]. Repercussions of early exercise on the formation of collateral lymphatic vessels and lymphatic flow to promote the prevention of lymphedema are not fully known [<xref rid="pone.0189176.ref014" ref-type="bibr">14</xref>]. Studies showed that women who performed exercises of progressive load had a reduced risk of developing lymphedema [<xref rid="pone.0189176.ref010" ref-type="bibr">10</xref>&#x02013;<xref rid="pone.0189176.ref015" ref-type="bibr">15</xref>]. Manual lymphatic drainage (MLD) is also widely used in women with lymphedema [<xref rid="pone.0189176.ref016" ref-type="bibr">16</xref>]. Lymphoscintigraphy studies showed that this technique promotes greater absorption of radiopharmaceuticals, possibly indicating a reduced risk for lymphedema [<xref rid="pone.0189176.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0189176.ref018" ref-type="bibr">18</xref>]. However, MLD and AE have not yet been compared long term clinical trials [<xref rid="pone.0189176.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0189176.ref020" ref-type="bibr">20</xref>].</p><p>On the other hand, there is no straightforward methodology to predict lymphedema formation, precluding the prescription of preventive measures, such as AE or MLD. Lymphoscintigraphy abnormalities have been found in patients with lymphedema, and the technique has been proposed as an early indicator of lymphedema [<xref rid="pone.0189176.ref018" ref-type="bibr">18</xref>, <xref rid="pone.0189176.ref021" ref-type="bibr">21</xref>]. In clinical research, lymphoscintigraphy of the upper limb has been used to investigate the association between the anatomy and function of the lymphatic system and the risk of developing lymphedema [<xref rid="pone.0189176.ref022" ref-type="bibr">22</xref>&#x02013;<xref rid="pone.0189176.ref025" ref-type="bibr">25</xref>], to examine the lymphatic functioning of patients with breast cancer-related lymphedema [<xref rid="pone.0189176.ref026" ref-type="bibr">26</xref>&#x02013;<xref rid="pone.0189176.ref028" ref-type="bibr">28</xref>], and to evaluate the effect of physical therapy [<xref rid="pone.0189176.ref029" ref-type="bibr">29</xref>,<xref rid="pone.0189176.ref030" ref-type="bibr">30</xref>] or surgical treatment [<xref rid="pone.0189176.ref031" ref-type="bibr">31</xref>] on the lymphatic system.</p><p>The aim of this study was thus to compare the long term (up to 30 months after surgery) effects of MLD and AE concerning 1) wound complications, 2) ROM recovery, 3) lymphatic parameters as described by lymphoscintigraphy; and 4) lymphedema formation. To our knowledge, this is the most comprehensive clinical trial assessing the rehabilitation of the upper limb in women with BC.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><sec id="sec007"><title>Subjects</title><p>In this clinical trial, we evaluated women undergoing unilateral mastectomy with lymph node dissection due to BC. Women were enrolled between November 2009 and August 2013, and followed-up through 2016. Patients were treated and followed in the Prof. Dr. Jos&#x000e9; Aristodemo Pinotti Women&#x02019;s Hospital&#x02013;Women&#x02019;s Integrated Healthcare Center (CAISM/Unicamp), in Brazil. Women undergoing immediate breast reconstruction were excluded. Also were excluded patients who: (a) before surgery had a difference in UL circumference greater than two centimeters; (b) had motor deficit or infection in the UL ipsilateral to surgery; (c) had undergone radiation therapy; and (d) those unable to understand the exercises proposed (see <xref ref-type="supplementary-material" rid="pone.0189176.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0189176.s002">S2</xref> Text).</p><p>Women who met the inclusion criteria were invited to participate in the study. Those who agreed to participate underwent evaluation at the Physical Therapy Outpatient Clinic of CAISM/Unicamp. One week before surgery, personal and clinical data were collected, UL circumference and goniometry were obtained and lymphoscintigraphy was scheduled. Women were matched for clinical staging, age (&#x000b1;10 years) and BMI, according to the following categories: low weight (&#x0003c;18.5 kg/m<sup>2</sup>); normal weight (&#x02265;18.5 and &#x02264;24.9 kg/m<sup>2</sup>); overweight (&#x02265;25 and &#x02264;29.9 kg/m<sup>2</sup>); and obesity (&#x02265;30 kg/m<sup>2</sup>) and divided into two groups: 52 received MLD and 53 performed active exercises.</p><p>Three women from the AE group and one from the MLD group were discontinued because they missed two consecutive treatment sessions (<xref ref-type="fig" rid="pone.0189176.g001">Fig 1</xref>).</p><fig id="pone.0189176.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.g001</object-id><label>Fig 1</label><caption><title>Flowchart of study sample.</title></caption><graphic xlink:href="pone.0189176.g001"/></fig><p>Sample size was estimated for a controlled non-randomized clinical trial, with a case ratio of 1:1. The prevalence assumed for adequate lymphatic function for the comparison group (exercise) was 52%. Assuming 80% power and 95% confidence intervals (p = 0.05, two-tailed), 48 patients were needed in each group (see <xref ref-type="supplementary-material" rid="pone.0189176.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0189176.s002">S2</xref> Text).</p></sec><sec id="sec008"><title>Lymphoscintigraphy</title><p>Patients underwent lymphoscintigraphy immediately before surgery, 2 and 30 months after surgery at the Nuclear Medicine Service of Unicamp, according to protocol described previously published by a study conducted at our service [<xref rid="pone.0189176.ref023" ref-type="bibr">23</xref>,<xref rid="pone.0189176.ref030" ref-type="bibr">30</xref>].</p><p>This analysis includes the velocity visualization of axillary lymph nodes (VVAL) and degree uptake in axillary lymph nodes (DUALN), classified according to <xref ref-type="table" rid="pone.0189176.t001">Table 1</xref> [<xref rid="pone.0189176.ref023" ref-type="bibr">23</xref>]. The presence or absence of radiopharmaceutical absorption by the liver (RAL), collateral circulation (CC) and dermal backflow (DBFL) were also analyzed. Liver absorption was classified as present when radiopharmaceutical uptake by the liver was visualized in any image; collateral circulation was classified as present when there was drainage of radioactive tracer by a lateral lymphatic vessel or uptake in an epitrochlear lymph node; and dermal backflow was classified as present when there was dermal dispersion of the radiopharmaceutical.</p><table-wrap id="pone.0189176.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.t001</object-id><label>Table 1</label><caption><title>Visual classification of upper limb lymphoscintigraphy.</title></caption><alternatives><graphic id="pone.0189176.t001g" xlink:href="pone.0189176.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="justify" rowspan="1" colspan="1">Score</th><th align="justify" rowspan="1" colspan="1">Velocity visualization of axillary lymph nodes (VVAL)</th><th align="center" rowspan="1" colspan="1">Score</th><th align="justify" rowspan="1" colspan="1">Degree uptake in axillary lymph nodes (DUALN)</th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">1</td><td align="justify" rowspan="1" colspan="1">Absent</td></tr><tr><td align="center" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">After two hours</td><td align="center" rowspan="1" colspan="1">2</td><td align="justify" rowspan="1" colspan="1">Mild</td></tr><tr><td align="center" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">After one hour</td><td align="center" rowspan="1" colspan="1">3</td><td align="justify" rowspan="1" colspan="1">Moderate</td></tr><tr><td align="center" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">At 10 minutes</td><td align="center" rowspan="1" colspan="1">4</td><td align="justify" rowspan="1" colspan="1">Intense</td></tr></tbody></table></alternatives></table-wrap></sec><sec id="sec009"><title>Physical evaluation</title><p>A physiotherapist evaluation was realized one week before surgery and personal and clinical data were collected. The wound was evaluated 2 months after surgery. ROM, upper limb circumference measurement and upper limb lymphoscintigraphy were performed before surgery, and 2 and 30 months after surgery [<xref rid="pone.0189176.ref011" ref-type="bibr">11</xref>, <xref rid="pone.0189176.ref030" ref-type="bibr">30</xref>].</p></sec><sec id="sec010"><title>Interventions</title><sec id="sec011"><title>Educational strategy (both groups)</title><p>On the first postoperative day, all participants were provided with information leaflets about proper care for the operated limb to prevent trauma, infection, and to avoid activities that involve too much loading and/or repetition; and daily active exercises to do at home. Furthermore, during the first month after surgery, patients attended lectures delivered by the multidisciplinary team of psychologists, nurses, social service workers and dietitians, composing the Rehabilitation Program for women undergoing breast cancer surgery [<xref rid="pone.0189176.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0189176.ref030" ref-type="bibr">30</xref>] (see <xref ref-type="supplementary-material" rid="pone.0189176.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0189176.s002">S2</xref> Text).</p></sec><sec id="sec012"><title>Manual lymphatic drainage (MLD) or active exercise (AE)</title><p>Forty-eight hours after surgery, women started the intervention (MLD or AE). Women assigned to MLD group began 40-min individual MLD sessions, twice a week, for 30 days, and those women assigned to the exercise group began 40-min group sessions (5&#x02013;20 women), twice a week, for 30 days. These techniques were thoroughly described in our previous publications [<xref rid="pone.0189176.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0189176.ref030" ref-type="bibr">30</xref>] (see <xref ref-type="supplementary-material" rid="pone.0189176.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0189176.s002">S2</xref> Text).</p></sec></sec><sec id="sec013"><title>Statistical analysis</title><p>Data were described by calculation of absolute (n) and relative (%) frequencies, mean, median and standard deviation. Group homogeneity was analyzed by Chi-square and Fisher&#x02019;s exact tests, for nominal and ordinal variables and by student&#x02019;s t-test and Mann&#x02013;Whitney tests for quantitative variables. We analyzed whether there was a VVAL and/or DUALN score trend related to the diagnosis of lymphedema and/or the study group using chi-squares for trends. In addition, we analyzed the association of RAL, CC and DBFL with lymphedema and treatment group using chi-squares. Next, we recoded the VVAL and DUALN scores from 1 to 4, and produced an interaction graph showing the mean values of the scores from baseline to 30 months after surgery. Then, we adjusted the analyses for patients&#x02019; age and BMI using linear (for VVAL and DUALN) and logistic (for RAL, CC and DBFL) regression models. Finally, we used a recursive partitioning algorithm to confirm the contribution of VVAL DUALN, RDFL, CC and RAL to the prediction of malignant lymphedema formation in up to 30 months postoperatively. Patients&#x02019; age, BMI, radio and chemotherapy, smoking habit and treatment (whether AE or MLD) were used as control variables in the recursive partitioning regression model. A conditional inference tree was generated from the model. The recursive partitioning algorithm was based on a linear regression model as described by Hothorn <italic>et al</italic>., to confirm the contribution of the lymphoscintigraphy parameters and control variables to the diagnosis of lymphedema. Conditional inference trees estimate a regression relationship by binary recursive partitioning in a conditional inference framework [<xref rid="pone.0189176.ref032" ref-type="bibr">32</xref>]. Basically, the algorithm works as follows: 1) the global null hypothesis of independence between any of the input variables (lymphoscintigraphy parameters and control variables) and the response (lymphedema) is tested, and the computation stopped if this hypothesis cannot be rejected. Otherwise the input variable with the strongest association to the response is selected. Branches of the generated inference tree bifurcate when a statistically significant association is detected (<italic>P</italic>&#x0003c;0.05). Mann-Whitney and Student&#x02019;s t-test were used to evaluate the association between shoulder ROM and presence of lymphedema. ANOVA for repeated measures was used to assess the shoulder ROM during follow-up. The software used for analysis was the R Environment for Statistical Computing (R Project). The level of significance adopted was 5%.</p></sec><sec id="sec014"><title>Ethics declaration</title><p>The authors confirm that all ongoing and related trials for this intervention are registered. The experiments comply with the current laws of the country in which they were performed. The study was approved by the Research Ethics Committee of Campinas State University (Protocol 1090/2009&#x02014;from 24<sup>th</sup> November 2009), according to the Declaration of Helsinki. All patients were informed and signed a free written consent term. Trial registration: Brazilian Registry of Clinical Trials: RBR-3dwp5r (<ext-link ext-link-type="uri" xlink:href="http://www.ensaiosclinicos.gov.br/rg/RBR-3dwp5r/">http://www.ensaiosclinicos.gov.br/rg/RBR-3dwp5r/</ext-link>) (see <xref ref-type="supplementary-material" rid="pone.0189176.s003">S3 Text</xref>).</p></sec></sec><sec sec-type="results" id="sec015"><title>Results</title><p><xref ref-type="table" rid="pone.0189176.t002">Table 2</xref> shows the comparison of the main clinical features of the women in the AE and MLD groups. Of the studied features, only exposure to neoadjuvant chemotherapy was imbalanced between groups: in the AE group, 45.3% of the women received neoadjuvant chemotherapy, contrasted to 67.9% of the women in the MLD group (p = 0.018). The incidence of wound complications did not differ between groups (<xref ref-type="table" rid="pone.0189176.t002">Table 2</xref>).</p><table-wrap id="pone.0189176.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.t002</object-id><label>Table 2</label><caption><title>Main clinical features of the women in the AE and MLD groups.</title></caption><alternatives><graphic id="pone.0189176.t002g" xlink:href="pone.0189176.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1"/><th align="center" colspan="2" rowspan="1">AE</th><th align="center" colspan="2" rowspan="1">MLD</th><th align="center" rowspan="2" colspan="1">p-value</th></tr><tr><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.84</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003c;55 years</td><td align="center" rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">41.5</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">45.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02265;55 years</td><td align="center" rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">58.5</td><td align="center" rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Body Mass Index</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.53</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x0003c;25 Kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">28.3</td><td align="center" rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">35.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;&#x02265;25 Kg/m<sup>2</sup></td><td align="center" rowspan="1" colspan="1">38</td><td align="char" char="." rowspan="1" colspan="1">71.7</td><td align="center" rowspan="1" colspan="1">34</td><td align="char" char="." rowspan="1" colspan="1">64.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Type of Surgery</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.0786<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MRM Patey</td><td align="center" rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="center" rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">35.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MRM Madden</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">45.3</td><td align="center" rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">62.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;RM Halsted</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Operated breast</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.8455</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Right</td><td align="center" rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="center" rowspan="1" colspan="1">28</td><td align="char" char="." rowspan="1" colspan="1">52.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Left</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">45.3</td><td align="center" rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">47.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dominant limb</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">1.0000<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Right</td><td align="center" rowspan="1" colspan="1">49</td><td align="char" char="." rowspan="1" colspan="1">92.2</td><td align="center" rowspan="1" colspan="1">50</td><td align="char" char="." rowspan="1" colspan="1">94.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Left</td><td align="center" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">7.5</td><td align="center" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">5.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Clinical Stage</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.0705<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;I</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">2.0</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;II</td><td align="center" rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">34.0</td><td align="center" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">18.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;III/IV</td><td align="center" rowspan="1" colspan="1">32</td><td align="char" char="." rowspan="1" colspan="1">64.0</td><td align="center" rowspan="1" colspan="1">43</td><td align="char" char="." rowspan="1" colspan="1">82.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Surgical Stage</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.0915<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;I</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;II</td><td align="center" rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">37.7</td><td align="center" rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">20.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;III/IV</td><td align="center" rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">58.5</td><td align="center" rowspan="1" colspan="1">41</td><td align="char" char="." rowspan="1" colspan="1">77.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Level of dissected lymph nodes</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.2703<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;1</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;2 or 3</td><td align="center" rowspan="1" colspan="1">51</td><td align="char" char="." rowspan="1" colspan="1">96.3</td><td align="center" rowspan="1" colspan="1">53</td><td align="char" char="." rowspan="1" colspan="1">100.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Neoadjuvant chemotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.0187</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">45.3</td><td align="center" rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">67.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">29</td><td align="char" char="." rowspan="1" colspan="1">54.7</td><td align="center" rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">32.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Adjuvant chemotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.0690</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">62.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">63.6</td><td align="center" rowspan="1" colspan="1">11</td><td align="char" char="." rowspan="1" colspan="1">37.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Radiotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.2901<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">72.7</td><td align="center" rowspan="1" colspan="1">26</td><td align="char" char="." rowspan="1" colspan="1">86.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">27.3</td><td align="center" rowspan="1" colspan="1">4</td><td align="char" char="." rowspan="1" colspan="1">13.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Irradiation</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.1783<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Plastron</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">6.3</td><td align="center" rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">23.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Plastron+SCF</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">87.5</td><td align="center" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">69.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Plastron+SCF+Axilla</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">7.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Plastron+SCF+Cervical region</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">6.3</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Hormone therapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.790<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">63.6</td><td align="center" rowspan="1" colspan="1">18</td><td align="char" char="." rowspan="1" colspan="1">60.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Immunotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">1.000<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">13.6</td><td align="center" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">19</td><td align="char" char="." rowspan="1" colspan="1">86.4</td><td align="center" rowspan="1" colspan="1">25</td><td align="char" char="." rowspan="1" colspan="1">83.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Shoulderhistory antecedentes</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.449<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Fracture</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">9.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Luxation</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">1.9</td><td align="center" rowspan="1" colspan="1">0</td><td align="char" char="." rowspan="1" colspan="1">0.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Bursitis</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">3.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Tendinitis</td><td align="center" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">9.6</td><td align="center" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">9.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Unknown pain</td><td align="center" rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">11.5</td><td align="center" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">17.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Absent</td><td align="center" rowspan="1" colspan="1">37</td><td align="char" char="." rowspan="1" colspan="1">71.2</td><td align="center" rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">59.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Heaviness sensation</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.3757</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">9</td><td align="char" char="." rowspan="1" colspan="1">36.0</td><td align="center" rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">64.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">48.1</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">51.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Smoking</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">1.0000<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1">3</td><td align="char" char="." rowspan="1" colspan="1">60.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">20</td><td align="char" char="." rowspan="1" colspan="1">42.5</td><td align="center" rowspan="1" colspan="1">27</td><td align="char" char="." rowspan="1" colspan="1">57.5</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Practice of exercises</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.4575</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">8</td><td align="char" char="." rowspan="1" colspan="1">36.4</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">63.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">14</td><td align="char" char="." rowspan="1" colspan="1">46.7</td><td align="center" rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">53.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Care UL</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.3481<xref ref-type="table-fn" rid="t002fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Follows daily</td><td align="center" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">68.2</td><td align="center" rowspan="1" colspan="1">17</td><td align="char" char="." rowspan="1" colspan="1">56.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Follows partly</td><td align="center" rowspan="1" colspan="1">5</td><td align="char" char="." rowspan="1" colspan="1">22.7</td><td align="center" rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No follows</td><td align="center" rowspan="1" colspan="1">2</td><td align="char" char="." rowspan="1" colspan="1">9.1</td><td align="center" rowspan="1" colspan="1">1</td><td align="char" char="." rowspan="1" colspan="1">3.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Seroma</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.2201</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">16</td><td align="char" char="." rowspan="1" colspan="1">40.0</td><td align="center" rowspan="1" colspan="1">24</td><td align="char" char="." rowspan="1" colspan="1">60.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">33</td><td align="char" char="." rowspan="1" colspan="1">52.4</td><td align="center" rowspan="1" colspan="1">30</td><td align="char" char="." rowspan="1" colspan="1">47.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Aspiration</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.1114</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">13</td><td align="char" char="." rowspan="1" colspan="1">37.1</td><td align="center" rowspan="1" colspan="1">22</td><td align="char" char="." rowspan="1" colspan="1">62.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">36</td><td align="char" char="." rowspan="1" colspan="1">53.7</td><td align="center" rowspan="1" colspan="1">31</td><td align="char" char="." rowspan="1" colspan="1">46.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dehiscence</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.8280</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">50.0</td><td align="center" rowspan="1" colspan="1">6</td><td align="char" char="." rowspan="1" colspan="1">50.0</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">46.7</td><td align="center" rowspan="1" colspan="1">48</td><td align="char" char="." rowspan="1" colspan="1">53.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Infection</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.2723</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">15</td><td align="char" char="." rowspan="1" colspan="1">55.6</td><td align="center" rowspan="1" colspan="1">12</td><td align="char" char="." rowspan="1" colspan="1">44.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">32</td><td align="char" char="." rowspan="1" colspan="1">43.2</td><td align="center" rowspan="1" colspan="1">42</td><td align="char" char="." rowspan="1" colspan="1">56.8</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>MRM = modified radical mastectomy; RM = radical mastectomy; SCF = supraclavicular fossa; UL = upper limbs/ Chi-Square test;</p></fn><fn id="t002fn002"><p>(*) Fisher&#x02019;s Exact test</p></fn></table-wrap-foot></table-wrap><p>The mean flexion and abduction ROM in the preoperative evaluation, 2 and 30 months postoperatively were similar in MLD and AE groups. For both groups, UL flexion and abduction were reduced 2 months after surgery compared to baseline, and partial recovery occurred 30 months after surgery. However, there was a significant time effect for shoulder flexion (&#x0003c;0,0001) and abduction (&#x0003c;0,0001) (<xref ref-type="fig" rid="pone.0189176.g002">Fig 2A and 2B</xref>).</p><fig id="pone.0189176.g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.g002</object-id><label>Fig 2</label><caption><title>Mean shoulder flexion (2A) and abduction (2B) at the preoperative of surgery, two and thirty months later, according to group.</title></caption><graphic xlink:href="pone.0189176.g002"/></fig><p>The cumulative incidence of lymphedema observed was 23.8% and did not differ between groups (p = 0.29) (Data not shown in tables).</p><p>In <xref ref-type="table" rid="pone.0189176.t003">Table 3</xref>, we dissect lymphoscintigraphy through its parameters DUALN, VVAL, DBFL, CC and RAL in relation to the cumulative incidence of lymphedema by the end of follow-up (from baseline to up to 30 months postoperatively). All analyses were adjusted for patients&#x02019; age and BMI. There was a significant convergent trend between baseline DUALN score (p = 0.003) and VVAL (p = 0.001) with lymphedema formation. The same was true for DUALN at 2 and 30 months (p&#x0003c;0.001 for both analyses), showing that DUALN is a powerful predictor of subsequent lymphedema. In other words, a reduced marker uptake (absent or mild DUALN) before or after surgery predicted lymphedema formation in the long run (&#x0003e;2 years). The DBFL, CC and RAL parameters were not associated with lymphedema formation. In <xref ref-type="table" rid="pone.0189176.t003">Table 3</xref>, we analyse whether the intervention (AE or MLD) was associated with the lymphocintigraphy parameters from baseline to up to 30 months after surgery. None of the studied parameters were shown to be associated with the intervention modality (AE or MLD).</p><table-wrap id="pone.0189176.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.t003</object-id><label>Table 3</label><caption><title>Lymphocintigraphy parameters DUALN, VVAL, DBFL, CC and RAL as related to cumulative incidence of lymphedema by the end of follow-up.</title></caption><alternatives><graphic id="pone.0189176.t003g" xlink:href="pone.0189176.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Lymphedema</th><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Lymphedema</th><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Lymphedema</th><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Lymphedema</th><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1">Lymphedema</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Yes (n = 15)</th><th align="center" rowspan="1" colspan="1">No (n = 48)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Yes (n = 15)</th><th align="center" rowspan="1" colspan="1">No (n = 48)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Yes (n = 15)</th><th align="center" rowspan="1" colspan="1">No (n = 48)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Yes (n = 15)</th><th align="center" rowspan="1" colspan="1">No (n = 48)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Yes (n = 15)</th><th align="center" rowspan="1" colspan="1">No (n = 48)</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n(%)</th><th align="center" rowspan="1" colspan="1">n(%)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n(%)</th><th align="center" rowspan="1" colspan="1">n(%)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n(%)</th><th align="center" rowspan="1" colspan="1">n(%)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n(%)</th><th align="center" rowspan="1" colspan="1">n(%)</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n(%)</th><th align="center" rowspan="1" colspan="1">n(%)</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">DUALN</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">VVAL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">DBFL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">CC</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">RAL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="center" rowspan="4" colspan="1"><bold>Baseline</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">4(15)</td><td align="center" rowspan="1" colspan="1">22(85)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">4 (15)</td><td align="center" rowspan="1" colspan="1">23 (85)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">0</td><td align="center" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">3(21)</td><td align="center" rowspan="1" colspan="1">11(79)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">5(21)</td><td align="center" rowspan="1" colspan="1">19(79)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">2(13)</td><td align="center" rowspan="1" colspan="1">13(87)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">5(21)</td><td align="center" rowspan="1" colspan="1">19 (79)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">14(24)</td><td align="center" rowspan="1" colspan="1">45(76)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">10(23)</td><td align="center" rowspan="1" colspan="1">34(77)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">10(26)</td><td align="center" rowspan="1" colspan="1">28(74)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">4(25)</td><td align="center" rowspan="1" colspan="1">12(75)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">1 (17)</td><td align="center" rowspan="1" colspan="1">5 (83)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">0.842</td></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">5(100)</td><td align="center" rowspan="1" colspan="1">0(0)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">5 (100)</td><td align="center" rowspan="1" colspan="1">0(0)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">0.003</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="4" colspan="1"><bold>2 months</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">2(12)</td><td align="center" rowspan="1" colspan="1">15(88)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">3(19)</td><td align="center" rowspan="1" colspan="1">13(81)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">1(33)</td><td align="center" rowspan="1" colspan="1">2(67)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">1(8)</td><td align="center" rowspan="1" colspan="1">12(92)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">10(23)</td><td align="center" rowspan="1" colspan="1">33(77)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">1(8)</td><td align="center" rowspan="1" colspan="1">12(92)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">3(12.5)</td><td align="center" rowspan="1" colspan="1">21(87.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">12(22)</td><td align="center" rowspan="1" colspan="1">43(78)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">14(31)</td><td align="center" rowspan="1" colspan="1">31(69)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">5(26)</td><td align="center" rowspan="1" colspan="1">14(73)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">9(39)</td><td align="center" rowspan="1" colspan="1">14(61)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">6(46)</td><td align="center" rowspan="1" colspan="1">7(54)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">0.1806</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">1</td></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">2(33)</td><td align="center" rowspan="1" colspan="1">4(67)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">2(33)</td><td align="center" rowspan="1" colspan="1">4(67)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">0.1115</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="4" colspan="1"><bold>30 months</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">0 (0)</td><td align="center" rowspan="1" colspan="1">2(100)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">0(0)</td><td align="center" rowspan="1" colspan="1">2(100)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">10(53)</td><td align="center" rowspan="1" colspan="1">9(47)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">6(22)</td><td align="center" rowspan="1" colspan="1">21(78)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">11(24)</td><td align="center" rowspan="1" colspan="1">35(76)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">6(37.5)</td><td align="center" rowspan="1" colspan="1">15(62.5)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">6(27)</td><td align="center" rowspan="1" colspan="1">15(73)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">5(12)</td><td align="center" rowspan="1" colspan="1">37(88)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9(26.5)</td><td align="center" rowspan="1" colspan="1">25(73.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">4(27)</td><td align="center" rowspan="1" colspan="1">11(73)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">5(33)</td><td align="center" rowspan="1" colspan="1">10(67)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">5(38.5)</td><td align="center" rowspan="1" colspan="1">10(61.5)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">4(27)</td><td align="center" rowspan="1" colspan="1">11(73)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">4(27)</td><td align="center" rowspan="1" colspan="1">11(73)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.975</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.105</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.998</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Trend)</td><td align="center" rowspan="1" colspan="1">0.1461</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>DUALN = degree uptake in axillary lymph nodes; VVAL = velocity visualization of axillary lymph nodes; classified according to <xref ref-type="table" rid="pone.0189176.t001">Table 1</xref>.<sup>11</sup> The presence or absence of radiopharmaceutical absorption by the liver (RAL), collateral circulation (CC) and dermal backflow (DBFL) were also analyzed</p></fn><fn id="t003fn002"><p>All analyses were adjusted for age and BMI</p></fn></table-wrap-foot></table-wrap><p><xref ref-type="table" rid="pone.0189176.t004">Table 4</xref> shows the clinical features and postoperative complications as related to lymphedema formation after 30 months of follow-up. None of the studied features or complications was individually associated with lymphedema. <xref ref-type="fig" rid="pone.0189176.g003">Fig 3</xref> shows the result from a partitioning recursive model fit to analyse the clinical factors associated with lymphedema. Clinical factors included in the model were: study group (either AE or MLD), age, BMI, clinical and surgical stage, chemo and radiotherapy and number of dissected lymph nodes. The display shows significant associations at branch bifurcations. Age &#x02264;39 years was the factor with the greatest association with lymphedema (p = 0.009). In women with age &#x02264;39 years, BMI &#x0003e;24Kg/m<sup>2</sup> was significantly associated with lymphedema (p = 0.017). In women over 39 years old, those who were allotted to MLD group were at a significantly higher risk of developing lymphedema than their counterparts allotted to the AE group (p = 0.011).</p><table-wrap id="pone.0189176.t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.t004</object-id><label>Table 4</label><caption><title>Lymphocintigraphy parameters DUALN, VVAL, DBFL, CC and RAL as related to the intervention group.</title></caption><alternatives><graphic id="pone.0189176.t004g" xlink:href="pone.0189176.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">AE</th><th align="center" rowspan="1" colspan="1">MLD</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">AE</th><th align="center" rowspan="1" colspan="1">MLD</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">AE</th><th align="center" rowspan="1" colspan="1">MLD</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">AE</th><th align="center" rowspan="1" colspan="1">MLD</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">AE</th><th align="center" rowspan="1" colspan="1">MLD</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n = 53</th><th align="center" rowspan="1" colspan="1">n = 53</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n = 53</th><th align="center" rowspan="1" colspan="1">n = 53</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n = 53</th><th align="center" rowspan="1" colspan="1">n = 53</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n = 53</th><th align="center" rowspan="1" colspan="1">n = 53</th><th align="left" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">n = 53</th><th align="center" rowspan="1" colspan="1">n = 53</th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">DUALN</th><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">VVAL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">DBFL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">CC</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">RAL</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="center" rowspan="4" colspan="1"><bold>Baseline</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">17(40.5)</td><td align="center" rowspan="1" colspan="1">25(59.5)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">21(47)</td><td align="center" rowspan="1" colspan="1">24(53)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">0(0)</td><td align="center" rowspan="1" colspan="1">2(100)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">14(58)</td><td align="center" rowspan="1" colspan="1">10(42)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">21(45)</td><td align="center" rowspan="1" colspan="1">26(55)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">16(55)</td><td align="center" rowspan="1" colspan="1">13(45)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">10(47.5)</td><td align="center" rowspan="1" colspan="1">21(52.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">47(48.5)</td><td align="center" rowspan="1" colspan="1">50(51.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">31(42.5)</td><td align="center" rowspan="1" colspan="1">42(57.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">32(55)</td><td align="center" rowspan="1" colspan="1">26(45)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">12(50)</td><td align="center" rowspan="1" colspan="1">12(50)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">5(50)</td><td align="center" rowspan="1" colspan="1">5(50)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">0.5202</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">0.2643</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">0.3827</td></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">8(80)</td><td align="center" rowspan="1" colspan="1">29(20)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">8(80)</td><td align="center" rowspan="1" colspan="1">2(20)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.224</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.148</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.360</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.108</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.19</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="4" colspan="1"><bold>2 months</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">9(41)</td><td align="center" rowspan="1" colspan="1">13(59)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">10(42)</td><td align="center" rowspan="1" colspan="1">14(58)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">1(25)</td><td align="center" rowspan="1" colspan="1">3(75)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">9(39)</td><td align="center" rowspan="1" colspan="1">14(61)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">37(51)</td><td align="center" rowspan="1" colspan="1">35(49)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">11(44)</td><td align="center" rowspan="1" colspan="1">14(56)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">19(49)</td><td align="center" rowspan="1" colspan="1">20(51)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">44(47)</td><td align="center" rowspan="1" colspan="1">49(53)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">40(52)</td><td align="center" rowspan="1" colspan="1">37(48)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">16(48.5)</td><td align="center" rowspan="1" colspan="1">17(51.5)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">16(47)</td><td align="center" rowspan="1" colspan="1">18(53)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">7(39)</td><td align="center" rowspan="1" colspan="1">11(61)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">0.7157</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">P</td><td align="center" rowspan="1" colspan="1">0.9473</td></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">8(53)</td><td align="center" rowspan="1" colspan="1">7(47)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">8(53)</td><td align="center" rowspan="1" colspan="1">7(47)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.491</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.374</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.412</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.631</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.948</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="4" colspan="1"><bold>30 months</bold></td><td align="left" rowspan="1" colspan="1">Intense</td><td align="center" rowspan="1" colspan="1">7(44)</td><td align="center" rowspan="1" colspan="1">9(56)</td><td align="left" rowspan="1" colspan="1">At 10 minute</td><td align="center" rowspan="1" colspan="1">7(64)</td><td align="center" rowspan="1" colspan="1">4(36)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">10(53)</td><td align="center" rowspan="1" colspan="1">9(47)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">17(61)</td><td align="center" rowspan="1" colspan="1">11(39)</td><td align="left" rowspan="1" colspan="1">Present</td><td align="center" rowspan="1" colspan="1">24(51)</td><td align="center" rowspan="1" colspan="1">23(49)</td></tr><tr><td align="left" rowspan="1" colspan="1">Moderate</td><td align="center" rowspan="1" colspan="1">10(62.5)</td><td align="center" rowspan="1" colspan="1">6(37.5)</td><td align="left" rowspan="1" colspan="1">After one hours</td><td align="center" rowspan="1" colspan="1">9(39)</td><td align="center" rowspan="1" colspan="1">14(61)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">23(53.5)</td><td align="center" rowspan="1" colspan="1">20(46.5)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">16(47)</td><td align="center" rowspan="1" colspan="1">18(53)</td><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9(60)</td><td align="center" rowspan="1" colspan="1">6(40)</td></tr><tr><td align="left" rowspan="1" colspan="1">Mild</td><td align="center" rowspan="1" colspan="1">7(47)</td><td align="center" rowspan="1" colspan="1">8(53)</td><td align="left" rowspan="1" colspan="1">After two hour</td><td align="center" rowspan="1" colspan="1">8(61.5)</td><td align="center" rowspan="1" colspan="1">5(38.5)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">0.4141</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p</td><td align="center" rowspan="1" colspan="1">0.759</td></tr><tr><td align="left" rowspan="1" colspan="1">Absent</td><td align="center" rowspan="1" colspan="1">9(60)</td><td align="center" rowspan="1" colspan="1">6(40)</td><td align="left" rowspan="1" colspan="1">Not visualized</td><td align="center" rowspan="1" colspan="1">9(60)</td><td align="center" rowspan="1" colspan="1">6(40)</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.975</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.105</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.998</td></tr><tr><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.85</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">p(Adjust)</td><td align="center" rowspan="1" colspan="1">0.81</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t004fn001"><p>DUALN = degree uptake in axillary lymph nodes; VVAL = velocity visualization of axillary lymph nodes; classified according to <xref ref-type="table" rid="pone.0189176.t001">Table 1</xref>.<sup>11</sup> The presence or absence of radiopharmaceutical absorption by the liver (RAL), collateral circulation (CC) and dermal backflow (DBFL) were also analyzed</p></fn><fn id="t004fn002"><p>All analyses were adjusted for age and BMI</p></fn></table-wrap-foot></table-wrap><fig id="pone.0189176.g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.g003</object-id><label>Fig 3</label><caption><title>Recursive partitioning showing the factors associated with the presence of lymphedema after 30 months of follow-up.</title></caption><graphic xlink:href="pone.0189176.g003"/></fig><p>On multivariate analysis, no relationship was found between development of lymphedema and flexion and abduction ROM of the UL ipsilateral to surgery in the postoperative evaluations (<xref ref-type="table" rid="pone.0189176.t005">Table 5</xref>).</p><table-wrap id="pone.0189176.t005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0189176.t005</object-id><label>Table 5</label><caption><title>Clinical features, postoperative complications and adjuvant treatment as related to the development of lymphedema after 30 months of follow-up.</title></caption><alternatives><graphic id="pone.0189176.t005g" xlink:href="pone.0189176.t005"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="3" colspan="1"/><th align="center" colspan="4" rowspan="1">Lymphedema</th><th align="center" rowspan="3" colspan="1">p-value</th></tr><tr><th align="center" colspan="2" rowspan="1">Yes</th><th align="center" colspan="2" rowspan="1">No</th></tr><tr><th align="center" rowspan="1" colspan="1">N</th><th align="center" rowspan="1" colspan="1">%</th><th align="center" rowspan="1" colspan="1">n</th><th align="center" rowspan="1" colspan="1">%</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><bold>Groups</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.3980</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;AE</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">30.6</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">69.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;MLD</td><td align="center" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">28.1</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">71.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Age</bold></td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">55.1&#x000b1;17.5</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">59.2&#x000b1;13.0</td><td align="char" char="." rowspan="1" colspan="1">0.4001</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>BMI (kg/m</bold><sup><bold>2</bold></sup><bold>)</bold></td><td align="center" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">28.07&#x000b1;5.96</td><td align="center" rowspan="1" colspan="1">48</td><td align="center" rowspan="1" colspan="1">28.37&#x000b1;5.96</td><td align="char" char="." rowspan="1" colspan="1">0.7066</td></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Seroma</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.4827</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">40.4</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">66.7</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">59.6</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Dehiscence</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.9126<xref ref-type="table-fn" rid="t005fn002">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">16.7</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">12.8</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">83.3</td><td align="center" rowspan="1" colspan="1">41</td><td align="center" rowspan="1" colspan="1">87.2</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Infection</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.2047</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">33.3</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">27.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">66.7</td><td align="center" rowspan="1" colspan="1">34</td><td align="center" rowspan="1" colspan="1">72.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Neoadjuvant chemotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.5944</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">75.0</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">52.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">25.0</td><td align="center" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">47.9</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Adjuvant chemotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.9419</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">80.0</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">54.3</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">20.0</td><td align="center" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">45.7</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><bold>Radiotherapy</bold></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.9440</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Yes</td><td align="center" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">82.4</td><td align="center" rowspan="1" colspan="1">35</td><td align="center" rowspan="1" colspan="1">76.1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;No</td><td align="center" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">17.6</td><td align="center" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">23.9</td><td align="center" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t005fn001"><p>Chi-Square test;</p></fn><fn id="t005fn002"><p>(*) Fisher&#x02019;s Exact test;</p></fn><fn id="t005fn003"><p>SCF = supraclavicular fossa; SD = standard deviation</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="conclusions" id="sec016"><title>Discussion</title><p>Our study clearly shows that MLD and AE for UL rehabilitation after breast cancer surgery produced similar effects on wound complications, ROM, and lymphoscintigraphy parameters in the short and long run. In addition, our study suggests that AE may be more effective than MLD for the prevention of lymphedema in women older than 39 years. It is also important to mention that the DUALN and VVALN lymphoscintigraphy parameters, when measured before surgery, can help discriminate women at higher risk of developing lymphedema after surgery, regardless of age, body mass index or whether the patient underwent AE or MLD. This prediction power is valid even for the presence of lymphedema in the long term (up to 30 months after surgery).</p><p>Studies found that performing exercises in the early postoperative period does not increase the incidence of seroma [<xref rid="pone.0189176.ref033" ref-type="bibr">33</xref>&#x02013;<xref rid="pone.0189176.ref035" ref-type="bibr">35</xref>] or infection [<xref rid="pone.0189176.ref036" ref-type="bibr">36</xref>,<xref rid="pone.0189176.ref037" ref-type="bibr">37</xref>]. In addition, although MLD improves lymphatic circulation, especially subcutaneous circulation and promotes the removal of interstitial fluid [<xref rid="pone.0189176.ref029" ref-type="bibr">29</xref>], a systematic review found no association between MLD and seroma formation [<xref rid="pone.0189176.ref036" ref-type="bibr">36</xref>].</p><p>Our findings show that shoulder flexion and abduction ROM decreased significantly in both groups during the first 60 days after surgery and partial recovery was obtained 30 months after surgery. Previous studies suggest that ROM restriction in the first months may be associated with lymph node dissection, number of dissected lymph nodes and compromised lymph nodes, mastectomy, advanced age, chemotherapy, radiotherapy, hormonal therapy and seroma [<xref rid="pone.0189176.ref038" ref-type="bibr">38</xref>,<xref rid="pone.0189176.ref039" ref-type="bibr">39</xref>].</p><p>MLD stimulate alternative drainage pathways, therefore its use in the early postoperative period can reduce the stagnation of proteins in the interstitial space and the risk of increased limb volume resulting from inflammation secondary to surgical damage, which interferes with the lymphatic drainage of the upper limb [<xref rid="pone.0189176.ref017" ref-type="bibr">17</xref>]. In a revision about conservative interventions for preventing lymphedema, Stuiver et al. (2015) [<xref rid="pone.0189176.ref036" ref-type="bibr">36</xref>] demonstrated that the effectiveness of MLD on lymphedema risk is still uncertain. Differences in effect observed in the studies that evaluated the effectiveness of MLD for preventing lymphedema [<xref rid="pone.0189176.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0189176.ref020" ref-type="bibr">20</xref>,<xref rid="pone.0189176.ref040" ref-type="bibr">40</xref>] may in part be ascribed to the methodological differences between studies, e.g. dosage and forms of administration of the MLD [<xref rid="pone.0189176.ref034" ref-type="bibr">34</xref>]. Only three controlled clinical trials studied the MLD effects on the prevention of lymphedema related to breast cancer. Two demonstrated that MLD administered early in the postoperative period can effectively prevent lymphedema [<xref rid="pone.0189176.ref020" ref-type="bibr">20</xref>, <xref rid="pone.0189176.ref040" ref-type="bibr">40</xref>], whereas the other considered that the addition of MLD did not reduce the incidence of lymphedema [<xref rid="pone.0189176.ref019" ref-type="bibr">19</xref>].</p><p>The impact of early AE administration in the formation of new vessels is also discussed [<xref rid="pone.0189176.ref014" ref-type="bibr">14</xref>]. It is believed that regular exercise stimulates lymphangiogenesis, which can reduce the damage caused by dissection and radiotherapy [<xref rid="pone.0189176.ref025" ref-type="bibr">25</xref>]. Lymphoscintigraphy results of women treated for breast cancer may be abnormal even in the absence of signs or symptoms [<xref rid="pone.0189176.ref025" ref-type="bibr">25</xref>]. However, two minutes of exercise normalized lymphatic pressure, accelerating lymph drainage [<xref rid="pone.0189176.ref041" ref-type="bibr">41</xref>]. In sheep with intact lymphatic system, undergoing short duration exercises, there was an increase in the frequency of lymphatic vessels contractions and lymph flow [<xref rid="pone.0189176.ref042" ref-type="bibr">42</xref>]. The exercise causes an increase in blood pressure and cardiac output, resulting in increased capillary filtration, which leads to an increase in interstitial pressure, facilitating entry of fluid and proteins into the lymph capillaries. Other authors observed that, during exercise, both mechanisms, intrinsic and extrinsic, are reinforced, increasing the propulsion of the lymph through the lymph vessels [<xref rid="pone.0189176.ref026" ref-type="bibr">26</xref>,<xref rid="pone.0189176.ref027" ref-type="bibr">27</xref>]. Regardless of what happens to the lymphatic vessels, the positive impact of exercise on muscle and cardiovascular systems seems to favor the removal and circulation of lymph [<xref rid="pone.0189176.ref043" ref-type="bibr">43</xref>].</p><p>As mentioned above, the mechanisms through which AE and MLD exert their effects on the lymphatic system are distinct. However, our study shows that their end results are similar, including lymphoscintigraphy parameters and prevention of clinically detectable lymphedema. Recently, a study with breast cancer patients scheduled for modified radical mastectomy randomly apportioned to undergo physical exercise only (n = 500) or self-MLD as well as exercise (n = 500) after surgery and followed for 12 months showed that self-MLD, in combination with physical exercise, is beneficial for breast cancer patients in preventing postmastectomy scar formation, upper limb lymphedema, and shoulder joint dysfunction [<xref rid="pone.0189176.ref044" ref-type="bibr">44</xref>]. It seems that in older people, lower physical activity, weakness of muscle pump, and higher BMI may increase edema [<xref rid="pone.0189176.ref005" ref-type="bibr">5</xref>]. This in turn may help explain our finding that older women benefited more from AE than MLD, since AE may have helped improve muscle strength.</p><p>Swelling may occur at any point following axillary node dissection or radiation therapy, beginning immediately after or even delayed by several years [<xref rid="pone.0189176.ref005" ref-type="bibr">5</xref>] and the incidence seems to increase up to 2 years after diagnosis or surgery of breast cancer [<xref rid="pone.0189176.ref002" ref-type="bibr">2</xref>]. Our findings revealed that lymphatic drainage pattern alterations were not related to the presence of signs during the first 2 months after surgery, while after 30 months, 23.9% of the women evaluated showed lymphedema. Meta-analysis of nine prospective cohort studies gives an incidence of lymphedema diagnosed by more than one method of 28.2% (mean; range 11.8%&#x02013;53.5%) [<xref rid="pone.0189176.ref002" ref-type="bibr">2</xref>].</p><p>The existing data on whether lymphedema incidence varies with age is inconsistent [<xref rid="pone.0189176.ref045" ref-type="bibr">45</xref>]. Hayes showed that age more than 50 may increase the risk of lymphedema incidence 3.3 times [<xref rid="pone.0189176.ref046" ref-type="bibr">46</xref>]. In addition, object arm circumferential measures are significantly higher in women &#x0003e;55years old compared to those made in younger patients [<xref rid="pone.0189176.ref047" ref-type="bibr">47</xref>]. However, our findings showed that lymphedema was associated with younger age at diagnosis and the same was observed in other studies [<xref rid="pone.0189176.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0189176.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0189176.ref021" ref-type="bibr">21</xref>]. The reason why older women are less likely to develop lymphedema later in the survival trajectory is unclear [<xref rid="pone.0189176.ref045" ref-type="bibr">45</xref>]. Reports show that older women who survived breast cancer are more likely to attribute their symptoms to aging or other comorbidities, whereas younger women, especially those who are active in work or engaged in recreational/parenthood activities, may be more aware of the limitations imposed by lymphedema [<xref rid="pone.0189176.ref021" ref-type="bibr">21</xref>].</p><p>We also detected an association of lymphedema risk and higher BMI. Although obesity is a major clinical risk factor for lymphedema, the mechanisms that regulate this effect remain unknown [<xref rid="pone.0189176.ref048" ref-type="bibr">48</xref>,<xref rid="pone.0189176.ref049" ref-type="bibr">49</xref>]. Recent reports have demonstrated that obesity is associated with acquired lymphatic dysfunction [<xref rid="pone.0189176.ref048" ref-type="bibr">48</xref>,<xref rid="pone.0189176.ref050" ref-type="bibr">50</xref>]. The hypothesis to explain obesity-induced lymphedema are that the lymphatics in the extremity are normal but the elevated pressure from the weight of the tissue or progressive skin folds also might collapse lymphatic vessels [<xref rid="pone.0189176.ref049" ref-type="bibr">49</xref>]; or yet to impaired baseline lymphatic clearance and an increased propensity for inflammation [<xref rid="pone.0189176.ref048" ref-type="bibr">48</xref>], fibrosis and adipose deposition may destroy lymph vessels and/or nodes [<xref rid="pone.0189176.ref005" ref-type="bibr">5</xref>,<xref rid="pone.0189176.ref048" ref-type="bibr">48</xref>&#x02013;<xref rid="pone.0189176.ref050" ref-type="bibr">50</xref>].</p><p>In the current study, a considerable number of women from both groups showed radiopharmaceutical VVALN and DUALN decrease in postoperative lymphoscintigraphy. This worsening occurred regardless of the rehabilitation technique employed and may be related to lymphatic system impairment caused by axillary dissection, surgical aggressiveness [<xref rid="pone.0189176.ref006" ref-type="bibr">6</xref>], altered scar formation and presence of seroma [<xref rid="pone.0189176.ref051" ref-type="bibr">51</xref>], as well as the preoperative constitution of lymphatic system [<xref rid="pone.0189176.ref028" ref-type="bibr">28</xref>,<xref rid="pone.0189176.ref052" ref-type="bibr">52</xref>]. This later effect may help explain why VVALN and DUALN parameters before surgery were associated with lymphedema formation after surgery. In this same line of thought, Cintolesi et al. observed that in women destined to develop lymphedema the lymphatic contractile work rate is already high and if this is raised further by increased resistance to axillaries drainage following cancer treatment and/or further increase in lymph load, the lymphatics are gradually tipped into chronic failure. The authors suggest an analogy to high preload and high after load cardiac failure in systemic hypertension, where the reduced lymphatic pump activity then leads to overt clinical edema [<xref rid="pone.0189176.ref052" ref-type="bibr">52</xref>].</p><p>In essence, our study shows that manual lymphatic drainage is as safe and effective as exercise in rehabilitation after breast cancer surgery. Also of note, our data clearly shows that lymphatic abnormalities precede lymphedema formation in BC patients. In younger women, obesity seems to be the major player in lymphedema development, and actions devoted to reduce body weight may be of great benefit to women undergoing surgery for BC. On the other hand, our study shows that in older women, interventions focused on improving muscle strength are pivotal in preventing lymphedema formation.</p><p>Studies have suggested the use of Kinesiotaping, extracorporeal shock wave therapy and low-level laser therapy in the treatment of lymphedema. Among the physiological effects of these resources are the improvement of microcirculation, activation of lymph drainage [<xref rid="pone.0189176.ref053" ref-type="bibr">53</xref>,<xref rid="pone.0189176.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0189176.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0189176.ref056" ref-type="bibr">56</xref>], increased lymphangiogenesis [<xref rid="pone.0189176.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0189176.ref055" ref-type="bibr">55</xref>,<xref rid="pone.0189176.ref056" ref-type="bibr">56</xref>], and decreased neutrophils, inflammation [<xref rid="pone.0189176.ref054" ref-type="bibr">54</xref>,<xref rid="pone.0189176.ref055" ref-type="bibr">55</xref>] and adipocyte count [<xref rid="pone.0189176.ref054" ref-type="bibr">54</xref>]. In this way, further research can be carried out to provide evidence of preventive effects of these resources in lymphedema formation.</p><sec id="sec017"><title>Study limitation</title><p>We believe that our study shows evidence that the MLD and AE effects are equivalent regarding postoperative morbidities in patients treated for BC. Our study, however, has some limitations. First, the study design is suboptimal, since this is not a randomized controlled trial. On the other hand, careful balancing of baseline characteristics and multivariate analyses were used to compensate for possible selection biases. Second, we have not included women who underwent sentinel lymph node biopsy, which is the current standard of care for many clinical situations. We acknowledge that this is a limiting analytical factor. Other exclusion criteria, such as previous radiotherapy and breast reconstruction, in our view, bring more benefits than detrimental effects to the analysis.</p></sec></sec><sec sec-type="conclusions" id="sec018"><title>Conclusion</title><p>MLD is as safe and effective as exercise in rehabilitation after breast cancer surgery. Both techniques have the same effect on ROM, wound, lymphatic parameters as described by lymphoscintigraphy and lymphedema incidence up to 30 months after surgery. Impaired absorption and lymph flow evaluated preoperatively by lymphoscintigraphy are predictors for the development of lymphedema in the long term.</p></sec><sec sec-type="supplementary-material" id="sec019"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0189176.s001"><label>S1 Text</label><caption><title>Final project.</title><p>(DOC)</p></caption><media xlink:href="pone.0189176.s001.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0189176.s002"><label>S2 Text</label><caption><title>Original study protocol.</title><p>(DOC)</p></caption><media xlink:href="pone.0189176.s002.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0189176.s003"><label>S3 Text</label><caption><title>CONSORT 2010 checklist.</title><p>(DOC)</p></caption><media xlink:href="pone.0189176.s003.doc"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The authors thank the S&#x000e3;o Paulo Research Foundation for funding the study (grant number 2014/14.190&#x02013;9 and 2009/14864-1) (<xref ref-type="supplementary-material" rid="pone.0189176.s003">S3 Text</xref>).</p></ack><ref-list><title>References</title><ref id="pone.0189176.ref001"><label>1</label><mixed-citation publication-type="journal"><name><surname>DeSantis</surname><given-names>CE</given-names></name>, <name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Mariotto</surname><given-names>AB</given-names></name>, <name><surname>Siegel</surname><given-names>RL</given-names></name>, <name><surname>Stein</surname><given-names>KD</given-names></name>, <name><surname>Kramer</surname><given-names>JL</given-names></name>, <etal>et al</etal>
<article-title>Cancer treatment and survivorship statistics, 2014</article-title>
<source>CA Cancer J Clin</source>. <year>2014</year>; <volume>64</volume>(<issue>4</issue>): <fpage>252</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3322/caac.21235">10.3322/caac.21235</ext-link></comment>
<pub-id pub-id-type="pmid">24890451</pub-id></mixed-citation></ref><ref id="pone.0189176.ref002"><label>2</label><mixed-citation publication-type="journal"><name><surname>Disipio</surname><given-names>T</given-names></name>, <name><surname>Rye</surname><given-names>S</given-names></name>, <name><surname>Newman</surname><given-names>B</given-names></name>, <name><surname>Hayes</surname><given-names>S</given-names></name>. <article-title>Incidence of unilateral arm lymphedema after breast cancer: a systematic review and meta-analysis</article-title>. <source>The Lancet Oncology</source>. <year>2013</year>;<volume>14</volume>(<issue>6</issue>): <fpage>500</fpage>&#x02013;<lpage>515</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(13)70076-7">10.1016/S1470-2045(13)70076-7</ext-link></comment>
<pub-id pub-id-type="pmid">23540561</pub-id></mixed-citation></ref><ref id="pone.0189176.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Sato</surname><given-names>F</given-names></name>, <name><surname>Kuroda</surname><given-names>Y</given-names></name>. <article-title>Subjective perception of post-operative functional impairment of the arm and its association with quality of life in breast cancer survivors within the first postoperative year</article-title>. <source>J. Jpn. Acad. Nurs. Sci</source>. <year>2008</year>; <volume>28</volume>, <fpage>28</fpage>&#x02013;<lpage>36</lpage>.</mixed-citation></ref><ref id="pone.0189176.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>De Groef</surname><given-names>A</given-names></name>, <name><surname>Kampen</surname><given-names>MV</given-names></name>, <name><surname>Dieltjens</surname><given-names>E</given-names></name>, <name><surname>Christiaens</surname><given-names>MR</given-names></name>, <name><surname>Neven</surname><given-names>P</given-names></name>, <name><surname>Geraerts</surname><given-names>I</given-names></name>, <name><surname>Devoogdt</surname><given-names>N</given-names></name>. <article-title>Effectiveness of postoperative physical therapy for upper-limb impairments after breast cancer treatment: a systematic review</article-title>. <source>Arch Phys Med Rehabil</source>. <year>2015</year>;<volume>96</volume>(<issue>6</issue>):<fpage>1140</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">25595999</pub-id></mixed-citation></ref><ref id="pone.0189176.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Shahpar</surname><given-names>H</given-names></name>, <name><surname>Atieh</surname><given-names>A</given-names></name>, <name><surname>Maryam</surname><given-names>A</given-names></name>, <name><surname>Fatemeh</surname><given-names>HS</given-names></name>, <name><surname>Massoome</surname><given-names>N</given-names></name>, <name><surname>Mandana</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Risk Factors of Lymph Edema in Breast Cancer Patients</article-title>. <source>International Journal of Breast Cancer</source>. <year>2013</year>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1155/2013/641818">10.1155/2013/641818</ext-link></comment>
<pub-id pub-id-type="pmid">23862068</pub-id></mixed-citation></ref><ref id="pone.0189176.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Fu</surname><given-names>MR</given-names></name>. <article-title>Breast cancer-related lymphedema: Symptoms, diagnosis, risk reduction, and management</article-title>. <source>World J Clin Oncol</source>. <year>2014</year>; <volume>5</volume>(<issue>3</issue>): <fpage>241</fpage>&#x02013;<lpage>247</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5306/wjco.v5.i3.241">10.5306/wjco.v5.i3.241</ext-link></comment>
<pub-id pub-id-type="pmid">25114841</pub-id></mixed-citation></ref><ref id="pone.0189176.ref007"><label>7</label><mixed-citation publication-type="journal"><name><surname>Testa</surname><given-names>A</given-names></name>, <name><surname>Iannace</surname><given-names>C</given-names></name>, <name><surname>Di Libero</surname><given-names>L</given-names></name>. <article-title>Strengths of early physical rehabilitation programs in surgical BC patients: results PF a randomized controlled study</article-title>. <source>Eur J Phys Rehabil Med</source>. <year>2014</year>; <volume>50</volume>: <fpage>275</fpage>&#x02013;<lpage>84</lpage>
<pub-id pub-id-type="pmid">24518147</pub-id></mixed-citation></ref><ref id="pone.0189176.ref008"><label>8</label><mixed-citation publication-type="journal"><name><surname>Nielsen</surname><given-names>I</given-names></name>, <name><surname>Gordon</surname><given-names>S</given-names></name>, <name><surname>Selby</surname><given-names>A</given-names></name>. <article-title>Breast cancer-related lymphoedema risk reduction advice: reduction advice: a challenge for health professionals</article-title>. <source>Cancer Treat Rev</source>. <year>2008</year>;<volume>34</volume>(<issue>7</issue>):<fpage>621</fpage>&#x02013;<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ctrv.2007.11.002">10.1016/j.ctrv.2007.11.002</ext-link></comment>
<pub-id pub-id-type="pmid">18691823</pub-id></mixed-citation></ref><ref id="pone.0189176.ref009"><label>9</label><mixed-citation publication-type="journal"><name><surname>Celebioglu</surname><given-names>F</given-names></name>, <name><surname>Perbeck</surname><given-names>L</given-names></name>, <name><surname>Frisell</surname><given-names>J</given-names></name>, <name><surname>Grondal</surname><given-names>E</given-names></name>, <name><surname>Svensson</surname><given-names>L</given-names></name>, <name><surname>Danielsson</surname><given-names>R</given-names></name>. <article-title>Lymph Drainage Studied by Lymphoscintigraphy in the Arms after Sentinel Node Biopsy Compared with Axillary Lymph Node Dissection Following Conservative BC Surgery</article-title>. <source>Acta Radiologica</source>. <year>2007</year>; <volume>48</volume>(<issue>5</issue>):<fpage>488</fpage>&#x02013;<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/02841850701305440">10.1080/02841850701305440</ext-link></comment>
<pub-id pub-id-type="pmid">17520423</pub-id></mixed-citation></ref><ref id="pone.0189176.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>Shah</surname><given-names>C</given-names></name>, <name><surname>Vicini</surname><given-names>FA</given-names></name>. <article-title>Breast cancer-related arm lymphedema: incidence rates, diagnostic techniques, optimal management and risk reduction strategies</article-title>. <source>Int. J. Radiation Oncology Biol. Phys</source>. <year>2011</year>; <volume>81</volume>(<issue>4</issue>): <fpage>907</fpage>&#x02013;<lpage>914</lpage>.</mixed-citation></ref><ref id="pone.0189176.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>de Oliveira</surname><given-names>MM</given-names></name>, <name><surname>de Rezende</surname><given-names>LF</given-names></name>, <name><surname>do Amaral</surname><given-names>MT</given-names></name>, <name><surname>Pinto e Silva</surname><given-names>MP</given-names></name>, <name><surname>Morais</surname><given-names>SS</given-names></name>, <name><surname>Gurgel</surname><given-names>MS</given-names></name>. <article-title>Manual lymphatic drainage versus exercise in the early postoperative period for breast cancer</article-title>. <source>Physiother Theory Pract</source>. <year>2014</year>; <volume>30</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3109/09593985.2013.876695">10.3109/09593985.2013.876695</ext-link></comment>
<pub-id pub-id-type="pmid">24410411</pub-id></mixed-citation></ref><ref id="pone.0189176.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Galantino</surname><given-names>ML</given-names></name>, <name><surname>Stout</surname><given-names>NL</given-names></name>. <article-title>Exercise interventions for upper limb dysfunction due to breast cancer treatment</article-title>. <source>Phys Ther</source>. <year>2013</year>;<volume>93</volume>(<issue>10</issue>):<fpage>1291</fpage>&#x02013;<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2522/ptj.20120049">10.2522/ptj.20120049</ext-link></comment>
<pub-id pub-id-type="pmid">23907077</pub-id></mixed-citation></ref><ref id="pone.0189176.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Scaffidi</surname><given-names>M</given-names></name>, <name><surname>Vulpiani</surname><given-names>MC</given-names></name>, <name><surname>Vetrano</surname><given-names>M</given-names></name>, <name><surname>Conforti</surname><given-names>F</given-names></name>, <name><surname>Marchetti</surname><given-names>MR</given-names></name>, <name><surname>Bonifacino</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Early rehabilitation reduces the onset of complications in the upper limb following breast cancer surgery</article-title>. <source>Eur J Phys Rehabil Med</source>. <year>2012</year>; <volume>48</volume>(<issue>4</issue>):<fpage>601</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="pmid">22510674</pub-id></mixed-citation></ref><ref id="pone.0189176.ref014"><label>14</label><mixed-citation publication-type="journal"><name><surname>Gashev</surname><given-names>AA</given-names></name>, <name><surname>Zawieja</surname><given-names>DC</given-names></name>. <article-title>Physiology of human lymphatic contractility: a historical perspective</article-title>. <source>Lymphology</source>
<year>2001</year>; <volume>34</volume>:<fpage>124</fpage>&#x02013;<lpage>34</lpage>. <pub-id pub-id-type="pmid">11549124</pub-id></mixed-citation></ref><ref id="pone.0189176.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Schmitz</surname><given-names>KH</given-names></name>, <name><surname>Ahmed</surname><given-names>RL</given-names></name>, <name><surname>Troxel</surname><given-names>AB</given-names></name>, <name><surname>Cheville</surname><given-names>A</given-names></name>, <name><surname>Lewis-Grant</surname><given-names>L</given-names></name>, <name><surname>Smith</surname><given-names>R</given-names></name>, <etal>et al</etal>
<article-title>Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial</article-title>. <source>JAMA</source>. <year>2010</year>; <volume>304</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jama.2010.1837">10.1001/jama.2010.1837</ext-link></comment>
<pub-id pub-id-type="pmid">21148134</pub-id></mixed-citation></ref><ref id="pone.0189176.ref016"><label>16</label><mixed-citation publication-type="journal"><name><surname>Cheville</surname><given-names>A</given-names></name>. <article-title>Prevention of lymphoedema after axillary surgery for BC</article-title>. <source>BMJ</source>. <year>2010</year>; <volume>340</volume>:<fpage>b5235</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.b5235">10.1136/bmj.b5235</ext-link></comment>
<pub-id pub-id-type="pmid">20068254</pub-id></mixed-citation></ref><ref id="pone.0189176.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Sarri</surname><given-names>AJ</given-names></name>, <name><surname>Moriguchi</surname><given-names>SM</given-names></name>, <name><surname>Dias</surname><given-names>R</given-names></name>, <name><surname>Peres</surname><given-names>SV</given-names></name>, <name><surname>DA Silva</surname><given-names>ET</given-names></name>, <name><surname>Koga</surname><given-names>KH</given-names></name>, <etal>et al</etal>
<article-title>Physiotherapeutic stimulation: Early prevention of lymphedema following axillary lymph node dissection for BC treatment</article-title>. <source>Experimental and Therapeutic Medicine</source>. <year>2010</year>; <volume>1</volume>: <fpage>147</fpage>&#x02013;<lpage>52</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3892/etm_00000024">10.3892/etm_00000024</ext-link></comment>
<pub-id pub-id-type="pmid">23136607</pub-id></mixed-citation></ref><ref id="pone.0189176.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Williams</surname><given-names>AF</given-names></name>, <name><surname>Vadgama</surname><given-names>A</given-names></name>, <name><surname>Franks</surname><given-names>PJ</given-names></name>, <name><surname>Mortimer</surname><given-names>PS</given-names></name>. <article-title>A randomized controlled crossover study of manual lymphatic drainage therapy in women with BC related lymphedema</article-title>. <source>European Journal of Cancer Care</source>. <year>2002</year>; <volume>11</volume>: <fpage>254</fpage>&#x02013;<lpage>261</lpage>. <pub-id pub-id-type="pmid">12492462</pub-id></mixed-citation></ref><ref id="pone.0189176.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Devoogdt</surname><given-names>N</given-names></name>, <name><surname>Christiaens</surname><given-names>MR</given-names></name>, <name><surname>Geraerts</surname><given-names>I</given-names></name>, <name><surname>Truijen</surname><given-names>S</given-names></name>, <name><surname>Smeets</surname><given-names>A</given-names></name>, <name><surname>Leunen</surname><given-names>K</given-names></name>, <etal>et al</etal>
<article-title>Effect of manual lymph drainage in addition to guidelines and exercise therapy on arm lymphoedema related to breast cancer: randomised controlled trial</article-title>. <source>BMJ</source>. <year>2011</year>; <volume>343</volume>:<fpage>d5326</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1136/bmj.d5326">10.1136/bmj.d5326</ext-link></comment>
<pub-id pub-id-type="pmid">21885537</pub-id></mixed-citation></ref><ref id="pone.0189176.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Lacomba</surname><given-names>MT</given-names></name>, <name><surname>Sanches</surname><given-names>MJY</given-names></name>, <name><surname>Goni</surname><given-names>AZ</given-names></name>, <name><surname>Prieto Merino</surname><given-names>D</given-names></name>, <name><surname>Mayoral del Moral</surname><given-names>O</given-names></name>, <name><surname>Cerezo T&#x000e9;llez</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical Trial</article-title>. <source>BMJ</source>. <year>2010</year>; <volume>340</volume>:<fpage>396</fpage>.</mixed-citation></ref><ref id="pone.0189176.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Armer</surname><given-names>J</given-names></name>, <name><surname>Fu</surname><given-names>MR</given-names></name>. <article-title>Age differences in post-breast cancer lymphedema signs and symptoms</article-title>. <source>Cancer Nurs</source>. <year>2005</year>; <volume>28</volume>:<fpage>200</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="pmid">15915063</pub-id></mixed-citation></ref><ref id="pone.0189176.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Bains</surname><given-names>SK</given-names></name>, <name><surname>Stanton</surname><given-names>AWB</given-names></name>, <name><surname>Cintolesi</surname><given-names>V</given-names></name>, <name><surname>Ballinger</surname><given-names>J</given-names></name>, <name><surname>Allen</surname><given-names>S</given-names></name>, <name><surname>Zammit</surname><given-names>C</given-names></name>
<etal>et al</etal>
<article-title>A constitutional predisposition to breast cancer-related lymphoedema and effect of axillary lymph node surgery on forearm muscle lymph flow</article-title>. <source>The Breast</source>. <year>2015</year>; <volume>24</volume>: <fpage>68</fpage>&#x02013;<lpage>74</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.breast.2014.11.010">10.1016/j.breast.2014.11.010</ext-link></comment>
<pub-id pub-id-type="pmid">25491189</pub-id></mixed-citation></ref><ref id="pone.0189176.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Rezende</surname><given-names>LF</given-names></name>, <name><surname>Pedras</surname><given-names>FV</given-names></name>, <name><surname>Ramos</surname><given-names>CD</given-names></name>, <name><surname>Gurgel</surname><given-names>MSC</given-names></name>. <article-title>Evaluation of lymphatic compensation by lymphoscintigraphy in the postoperative period of breast cancer surgery with axillary dissection</article-title>. <source>Tumori</source>. <year>2011</year>; <volume>97</volume>: <fpage>309</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="pmid">21789008</pub-id></mixed-citation></ref><ref id="pone.0189176.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>O&#x02019;Mahony</surname><given-names>S</given-names></name>, <name><surname>Britton</surname><given-names>TM</given-names></name>, <name><surname>Solanki</surname><given-names>CK</given-names></name>, <etal>et al</etal>
<article-title>Lymphatic transfer studies with immunoglobulin scintigraphy after axillary surgery</article-title>. <source>Eur J Surg Oncol</source>. <year>2007</year>; <volume>33</volume>:<fpage>1052</fpage>&#x02013;<lpage>1060</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ejso.2007.03.012">10.1016/j.ejso.2007.03.012</ext-link></comment>
<pub-id pub-id-type="pmid">17499475</pub-id></mixed-citation></ref><ref id="pone.0189176.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Devoogdt</surname><given-names>N</given-names></name>, <name><surname>Van den Wyngaert</surname><given-names>T</given-names></name>, <name><surname>Bourgeois</surname><given-names>P</given-names></name>, <name><surname>Lambrechts</surname><given-names>M</given-names></name>, <name><surname>Van Kampen</surname><given-names>M</given-names></name>, <name><surname>Groef</surname><given-names>AD</given-names></name>, <name><surname>Geraerts</surname><given-names>I</given-names></name>
<etal>et al</etal>
<article-title>Reproducibility of Lymphoscintigraphic Evaluation of the Upper Limb</article-title>. <source>Lymphatic Research and Biology</source>. <year>2014</year>; <volume>12</volume>(<issue>3</issue>). <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/lrb.2013.0034">10.1089/lrb.2013.0034</ext-link></comment>
<pub-id pub-id-type="pmid">25144836</pub-id></mixed-citation></ref><ref id="pone.0189176.ref026"><label>26</label><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>KN</given-names></name>, <name><surname>Dolan</surname><given-names>LB</given-names></name>, <name><surname>Worsley</surname><given-names>D</given-names></name>, <name><surname>McKenzie</surname><given-names>DC</given-names></name>. <article-title>Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls</article-title>. <source>J Appl Physiol</source>. <year>2007</year>;<volume>103</volume>:<fpage>917</fpage>&#x02013;<lpage>925</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/japplphysiol.00077.2007">10.1152/japplphysiol.00077.2007</ext-link></comment>
<pub-id pub-id-type="pmid">17585046</pub-id></mixed-citation></ref><ref id="pone.0189176.ref027"><label>27</label><mixed-citation publication-type="journal"><name><surname>Modi</surname><given-names>S</given-names></name>, <name><surname>Stanton</surname><given-names>AW</given-names></name>, <name><surname>Svensson</surname><given-names>WE</given-names></name>, <name><surname>Peters</surname><given-names>AM</given-names></name>, <name><surname>Mortimer</surname><given-names>PS</given-names></name>, <name><surname>Levick</surname><given-names>JR</given-names></name>. <article-title>Human lymphatic pumping measured in healthy and lymphedematous arms by lymphatic congestion lymphoscintigraphy</article-title>. <source>J Physiol</source>. <year>2007</year>; <volume>583</volume>:<fpage>271</fpage>&#x02013;<lpage>285</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1113/jphysiol.2007.130401">10.1113/jphysiol.2007.130401</ext-link></comment>
<pub-id pub-id-type="pmid">17569739</pub-id></mixed-citation></ref><ref id="pone.0189176.ref028"><label>28</label><mixed-citation publication-type="journal"><name><surname>Stanton</surname><given-names>AW</given-names></name>, <name><surname>Modi</surname><given-names>S</given-names></name>, <name><surname>Mellor</surname><given-names>RH</given-names></name>, <name><surname>Levick</surname><given-names>JR</given-names></name>, <name><surname>Mortimer</surname><given-names>PS</given-names></name>. <article-title>Recent advances in breast cancer-related lymphedema of the arm: Lymphatic pump failure and predisposing factors</article-title>. <source>Lymphatic Research Biology</source>. <year>2009</year>; <volume>7</volume>:<fpage>29</fpage>&#x02013;<lpage>45</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/lrb.2008.1026">10.1089/lrb.2008.1026</ext-link></comment>
<pub-id pub-id-type="pmid">19302022</pub-id></mixed-citation></ref><ref id="pone.0189176.ref029"><label>29</label><mixed-citation publication-type="journal"><name><surname>Ferrandez</surname><given-names>JC</given-names></name>, <name><surname>Laroche</surname><given-names>JP</given-names></name>, <name><surname>Serin</surname><given-names>D</given-names></name>, <name><surname>Felix-Faure</surname><given-names>C</given-names></name>, <name><surname>Vinot</surname><given-names>JM</given-names></name>. <article-title>Lymphoscintigraphic aspects of the effects of manual lymphatic drainage</article-title>]. <source>J Mal Vasc</source>. <year>1996</year>; <volume>21</volume>:<fpage>283</fpage>&#x02013;<lpage>289</lpage>. <pub-id pub-id-type="pmid">9026543</pub-id></mixed-citation></ref><ref id="pone.0189176.ref030"><label>30</label><mixed-citation publication-type="journal"><name><surname>Oliveira</surname><given-names>MMF</given-names></name>, <name><surname>Gurgel</surname><given-names>MSC</given-names></name>, <name><surname>Amaral</surname><given-names>MTP</given-names></name>, <name><surname>Amorim</surname><given-names>BJ</given-names></name>, <name><surname>Ramos</surname><given-names>CD</given-names></name>, <name><surname>Almeida Filho</surname><given-names>JG</given-names></name>, <name><surname>Rezende</surname><given-names>LF</given-names></name>, <name><surname>Sarian</surname><given-names>LOZ</given-names></name>. <article-title>Manual lymphatic drainage and active exercises effects on lymphatic function do not translate into morbidities in women who underwent breast cancer surgery</article-title>. <source>Accepted to publication on Archives of Physical Medicine and Rehabilitation</source>. <year>2016</year></mixed-citation></ref><ref id="pone.0189176.ref031"><label>31</label><mixed-citation publication-type="journal"><name><surname>Damstra</surname><given-names>RJ</given-names></name>, <name><surname>Voesten</surname><given-names>HG</given-names></name>, <name><surname>van Schelven</surname><given-names>WD</given-names></name>, <name><surname>van der Lei</surname><given-names>B</given-names></name>. <article-title>Lymphatic venous anastomosis (LVA) for treatment of secondary arm lymphedema. A prospective study of 11 LVA procedures in 10 patients with breast cancer related lymphedema and a critical review of the literature</article-title>. <source>Breast Cancer Res Treat</source>. <year>2009</year>; <volume>113</volume>:<fpage>199</fpage>&#x02013;<lpage>206</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-008-9932-5">10.1007/s10549-008-9932-5</ext-link></comment>
<pub-id pub-id-type="pmid">18270813</pub-id></mixed-citation></ref><ref id="pone.0189176.ref032"><label>32</label><mixed-citation publication-type="journal"><name><surname>Hothorn</surname><given-names>T</given-names></name>, <name><surname>Hornik</surname><given-names>K</given-names></name>, <name><surname>Zeileis</surname><given-names>A</given-names></name>. <article-title>Unbiased Recursive Partitioning: A Conditional Inference Framework</article-title>.<source>Journal of Computational and Graphical Statistics</source>. <year>2006</year>; <volume>15</volume>, <issue>Iss. 3</issue></mixed-citation></ref><ref id="pone.0189176.ref033"><label>33</label><mixed-citation publication-type="journal"><name><surname>McNeely</surname><given-names>ML</given-names></name>, <name><surname>Campbell</surname><given-names>K</given-names></name>, <name><surname>Ospina</surname><given-names>M</given-names></name>, <name><surname>Rowe</surname><given-names>BH</given-names></name>, <name><surname>Dabbs</surname><given-names>K</given-names></name>, <name><surname>Klassen</surname><given-names>TP</given-names></name>, <etal>et al</etal>
<article-title>Exercise interventions for upper-limb dysfunction due to breast cancer treatment</article-title>. <source>Cochrane Database Syst Rev</source>. <year>2010</year>;<volume>16</volume>(<issue>6</issue>):<fpage>CD005211</fpage>.</mixed-citation></ref><ref id="pone.0189176.ref034"><label>34</label><mixed-citation publication-type="journal"><name><surname>Karki</surname><given-names>A</given-names></name>, <name><surname>Simonen</surname><given-names>R</given-names></name>, <name><surname>Malkia</surname><given-names>E</given-names></name>, <name><surname>Selfe</surname><given-names>J</given-names></name>. <article-title>Efficacy of physical therapy methods and exercise after a breast cancer operation: a systematic review</article-title>. <source>Critical Reviews in Physical and Rehabilitation Medicine</source>. <year>2001</year>;<volume>13</volume>(<issue>2</issue>):<fpage>159</fpage>&#x02013;<lpage>190</lpage>.</mixed-citation></ref><ref id="pone.0189176.ref035"><label>35</label><mixed-citation publication-type="journal"><name><surname>Shamley</surname><given-names>DR</given-names></name>, <name><surname>Barker</surname><given-names>K</given-names></name>, <name><surname>Simonite</surname><given-names>V</given-names></name>, <name><surname>Beardshaw</surname><given-names>A</given-names></name>. <article-title>Delayed versus Immediate Exercises following Surgery for Breast Cancer: a systematic review</article-title>. <source>Breast Cancer Res Treat</source>. <year>2005</year>;<volume>90</volume>(<issue>3</issue>):<fpage>263</fpage>&#x02013;<lpage>71</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-004-4727-9">10.1007/s10549-004-4727-9</ext-link></comment>
<pub-id pub-id-type="pmid">15830140</pub-id></mixed-citation></ref><ref id="pone.0189176.ref036"><label>36</label><mixed-citation publication-type="journal"><name><surname>Stuiver</surname><given-names>MM</given-names></name>, <name><surname>ten Tusscher</surname><given-names>MR</given-names></name>, <name><surname>Agasi-Idenburg</surname><given-names>CS</given-names></name>, <name><surname>Lucas</surname><given-names>C</given-names></name>, <name><surname>Aaronson</surname><given-names>NK</given-names></name>, <name><surname>Bossuyt</surname><given-names>PMM</given-names></name>. <article-title>Conservative interventions for preventing clinically detectable upper-limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy</article-title>. <source>Cochrane Database of Systematic Reviews</source>. <year>2015</year>; <volume>2</volume> Art. No.: CD009765. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/14651858.CD009765.pub2">10.1002/14651858.CD009765.pub2</ext-link></comment>
<pub-id pub-id-type="pmid">25677413</pub-id></mixed-citation></ref><ref id="pone.0189176.ref037"><label>37</label><mixed-citation publication-type="journal"><name><surname>Cinar</surname><given-names>M</given-names></name>, <name><surname>Seckin</surname><given-names>U</given-names></name>, <name><surname>Keskin</surname><given-names>D</given-names></name>, <name><surname>Bodur</surname><given-names>H</given-names></name>, <name><surname>Bozkurt</surname><given-names>B</given-names></name>, <name><surname>Cengiz</surname><given-names>O</given-names></name>. <article-title>The effectiveness of early rehabilitation in patients with modified radical mastectomy</article-title>. <source>Cancer Nurs</source>. <year>2008</year>;<volume>31</volume>(<issue>2</issue>):<fpage>160</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="pmid">18490892</pub-id></mixed-citation></ref><ref id="pone.0189176.ref038"><label>38</label><mixed-citation publication-type="journal"><name><surname>Do Nascimento</surname><given-names>SL</given-names></name>, <name><surname>de Oliveira</surname><given-names>RR</given-names></name>, <name><surname>de Oliveira</surname><given-names>MMF</given-names></name>, <name><surname>do Amaral</surname><given-names>MTP</given-names></name>. <article-title>Complica&#x000e7;&#x000f5;es e condutas fisioterap&#x000ea;uticas ap&#x000f3;s cirurgia por c&#x000e2;ncer de mama: estudo retrospectivo</article-title>. <source>Fisioter Pesq</source>. <year>2012</year>;<volume>19</volume>(<issue>3</issue>):<fpage>248</fpage>&#x02013;<lpage>255</lpage>.</mixed-citation></ref><ref id="pone.0189176.ref039"><label>39</label><mixed-citation publication-type="journal"><name><surname>Levy</surname><given-names>EW</given-names></name>, <name><surname>Pfalzer</surname><given-names>L</given-names></name>, <name><surname>Danoff</surname><given-names>J</given-names></name>, <name><surname>Springer</surname><given-names>BA</given-names></name>, <name><surname>McGarvey</surname><given-names>C</given-names></name>, <name><surname>Shieh</surname><given-names>CY</given-names></name>, <etal>et al</etal>
<article-title>Predictors of functional shoulder recovery at 1 and 12 months after breast cancer surgery</article-title>. <source>Breast Cancer Res Treat</source>. <year>2012</year>;<volume>134</volume>(<issue>1</issue>):<fpage>315</fpage>&#x02013;<lpage>24</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-012-2061-1">10.1007/s10549-012-2061-1</ext-link></comment>
<pub-id pub-id-type="pmid">22527107</pub-id></mixed-citation></ref><ref id="pone.0189176.ref040"><label>40</label><mixed-citation publication-type="journal"><name><surname>Zimmermann</surname><given-names>A</given-names></name>, <name><surname>Wozniewski</surname><given-names>M</given-names></name>, <name><surname>Szklarska</surname><given-names>A</given-names></name>, <name><surname>Lipowicz</surname><given-names>A</given-names></name>, <name><surname>Szuba</surname><given-names>A</given-names></name>. <article-title>Efficacy of manual lymphatic drainage in preventing secondary lymphedema after breast cancer surgery</article-title>. <source>Lymphology</source>. <year>2012</year>; <volume>45</volume>(<issue>3</issue>):<fpage>103</fpage>&#x02013;<lpage>12</lpage>. <pub-id pub-id-type="pmid">23342930</pub-id></mixed-citation></ref><ref id="pone.0189176.ref041"><label>41</label><mixed-citation publication-type="journal"><name><surname>Tartaglione</surname><given-names>G</given-names></name>, <name><surname>Pagan</surname><given-names>M</given-names></name>, <name><surname>Morese</surname><given-names>R</given-names></name>, <name><surname>Cappellini</surname><given-names>GA</given-names></name>, <name><surname>Zappal&#x000e0;</surname><given-names>AR</given-names></name>, <name><surname>Sebastiani</surname><given-names>C</given-names></name>, <etal>et al</etal>
<article-title>Intradermal lymphoscintigraphy at rest and after exercise: a new technique for the functional assessment of the lymphatic system in patients with lymphoedema</article-title>. <source>Nucl Med Commun</source>. <year>2010</year>; <volume>31</volume>(<issue>6</issue>):<fpage>547</fpage>&#x02013;<lpage>51</lpage>.<pub-id pub-id-type="pmid">20215978</pub-id></mixed-citation></ref><ref id="pone.0189176.ref042"><label>42</label><mixed-citation publication-type="journal"><name><surname>McGeown</surname><given-names>JG</given-names></name>, <name><surname>McHale</surname><given-names>NG</given-names></name>, <name><surname>Thornbury</surname><given-names>KD</given-names></name>. <article-title>The role of external compression and movement in lymph propulsion in the sheep hind limb</article-title>. <source>J Physiol</source>.<year>1987</year>; <volume>387</volume>(<issue>1</issue>):<fpage>83</fpage>&#x02013;<lpage>93</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1113/jphysiol.1987.sp016564">http://dx.doi.org/10.1113/jphysiol.1987.sp016564</ext-link>. <pub-id pub-id-type="pmid">3656186</pub-id></mixed-citation></ref><ref id="pone.0189176.ref043"><label>43</label><mixed-citation publication-type="journal"><name><surname>Lane</surname><given-names>K</given-names></name>, <name><surname>Worsley</surname><given-names>D</given-names></name>, <name><surname>Mckenzie</surname><given-names>D</given-names></name>. <article-title>Exercise and the lymphatic system: implications for breast-cancer survivors</article-title>. <source>Sport Med</source>. <year>2005</year>; <volume>35</volume>(<issue>6</issue>):<fpage>461</fpage>&#x02013;<lpage>71</lpage>.</mixed-citation></ref><ref id="pone.0189176.ref044"><label>44</label><mixed-citation publication-type="journal"><name><surname>Clark</surname><given-names>B</given-names></name>, <name><surname>Sitzia</surname><given-names>J</given-names></name>, <name><surname>Harlow</surname><given-names>W</given-names></name>. <article-title>Incidence and risk of arm oedema following treatment for breast cancer: a three-year follow-up study</article-title>. <source>QJM</source>. <year>2005</year>; <volume>98</volume>(<issue>5</issue>):<fpage>343</fpage>&#x02013;<lpage>8</lpage>. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/qjmed/hci053">http://dx.doi.org/10.1093/qjmed/hci053</ext-link>.<pub-id pub-id-type="pmid">15820971</pub-id></mixed-citation></ref><ref id="pone.0189176.ref045"><label>45</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>L</given-names></name>, <name><surname>Fan</surname><given-names>A</given-names></name>, <name><surname>Yan</surname><given-names>Jun</given-names></name>, <name><surname>He</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Zhang</surname><given-names>H</given-names></name>
<etal>et al</etal>
<article-title>Combining Manual Lymph Drainage with Physical Exercise after Modified Radical Mastectomy Effectively Prevents Upper Limb Lymphedema</article-title>. <source>Lymphatic Research and Biology</source>. <year>2016</year>; <volume>14</volume>(<issue>2</issue>): <fpage>104</fpage>&#x02013;<lpage>108</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/lrb.2015.0036">10.1089/lrb.2015.0036</ext-link></comment>
<pub-id pub-id-type="pmid">26824722</pub-id></mixed-citation></ref><ref id="pone.0189176.ref046"><label>46</label><mixed-citation publication-type="journal"><name><surname>Togawa</surname><given-names>K</given-names></name>, <name><surname>Ma</surname><given-names>H</given-names></name>, <name><surname>Sullivan-Halley</surname><given-names>J</given-names></name>, <name><surname>Neuhouser</surname><given-names>ML</given-names></name>, <name><surname>Imayama</surname><given-names>I</given-names></name>, <name><surname>Baumgartner</surname><given-names>KB</given-names></name>, <etal>et al</etal>
<article-title>Risk factors for self-reported arm lymphedema among reported arm lymphedema among female breast cancer survivors: a prospective cohort study</article-title>. <source>Breast Cancer Res</source>. <year>2014</year>;<volume>16</volume>(<issue>4</issue>):<fpage>414</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1186/s13058-014-0414-x">10.1186/s13058-014-0414-x</ext-link></comment>
<pub-id pub-id-type="pmid">25145603</pub-id></mixed-citation></ref><ref id="pone.0189176.ref047"><label>47</label><mixed-citation publication-type="journal"><name><surname>Kiel</surname><given-names>K</given-names></name>, <name><surname>Rademacker</surname><given-names>AW</given-names></name>. <article-title>Early-stage breast cancer: arm edema after wide excision and breast irradiation</article-title>. <source>Radiology</source>
<year>1996</year>;<volume>198</volume>:<fpage>279</fpage>&#x02013;<lpage>83</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1148/radiology.198.1.8539394">10.1148/radiology.198.1.8539394</ext-link></comment>
<pub-id pub-id-type="pmid">8539394</pub-id></mixed-citation></ref><ref id="pone.0189176.ref048"><label>48</label><mixed-citation publication-type="journal"><name><surname>Meeske</surname><given-names>KA</given-names></name>, <name><surname>Sullivan-Halley</surname><given-names>J</given-names></name>, <name><surname>Smith</surname><given-names>AW</given-names></name>, <name><surname>McTiernan</surname><given-names>A</given-names></name>, <name><surname>Baumgartner</surname><given-names>KB</given-names></name>, <name><surname>Harlan</surname><given-names>LC</given-names></name>, <etal>et al</etal>
<article-title>Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White women</article-title>. <source>Breast Cancer Research and Treatment</source>. <year>2009</year>; <volume>113</volume>(<issue>2</issue>): <fpage>383</fpage>&#x02013;<lpage>391</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10549-008-9940-5">10.1007/s10549-008-9940-5</ext-link></comment>
<pub-id pub-id-type="pmid">18297429</pub-id></mixed-citation></ref><ref id="pone.0189176.ref049"><label>49</label><mixed-citation publication-type="journal"><name><surname>Weitman</surname><given-names>ES</given-names></name>, <name><surname>Aschen</surname><given-names>SZ</given-names></name>, <name><surname>Farias-Eisner</surname><given-names>G</given-names></name>, <name><surname>Albano</surname><given-names>N</given-names></name>, <name><surname>Cuzzone</surname><given-names>DA</given-names></name>, <name><surname>Ghanta</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Obesity impairs lymphatic fluid transport and dendritic cell migration to lymph nodes</article-title>. <source>PLOS ONE</source>. <year>2013</year>;<volume>8</volume>(<issue>8</issue>):<fpage>e70703</fpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0070703">10.1371/journal.pone.0070703</ext-link></comment>
<pub-id pub-id-type="pmid">23950984</pub-id></mixed-citation></ref><ref id="pone.0189176.ref050"><label>50</label><mixed-citation publication-type="journal"><name><surname>Greene</surname></name>, <name><surname>Grant</surname><given-names>FD</given-names></name>, <name><surname>Slavin</surname><given-names>SA</given-names></name>, <name><surname>Maclellan</surname><given-names>RA</given-names></name>. <source>Obesity-Induced Lymphedema: Clinical and Lymphoscintigraphic Features</source>. <year>2015</year>; <volume>35</volume>.</mixed-citation></ref><ref id="pone.0189176.ref051"><label>51</label><mixed-citation publication-type="journal"><name><surname>Savetsky</surname><given-names>IL</given-names></name>, <name><surname>Torrisi</surname><given-names>JS</given-names></name>, <name><surname>Cuzzone</surname><given-names>DA</given-names></name>, <name><surname>Ghanta</surname><given-names>S</given-names></name>, <name><surname>Albano</surname><given-names>NJ</given-names></name>, <name><surname>Gardenier</surname><given-names>JC</given-names></name>, <etal>et al</etal>
<article-title>Obesity increases inflammation and impairs lymphatic function in a mouse model of lymphedema</article-title>. <source>Am J Physiol Heart Circ Physiol</source>. <year>2014</year>; <volume>307</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1152/ajpheart.00244.2014">10.1152/ajpheart.00244.2014</ext-link></comment>
<pub-id pub-id-type="pmid">24858842</pub-id></mixed-citation></ref><ref id="pone.0189176.ref052"><label>52</label><mixed-citation publication-type="journal"><name><surname>Monleon</surname><given-names>S</given-names></name>, <name><surname>Murta-Nascimento</surname><given-names>C</given-names></name>, <name><surname>Bascuas</surname><given-names>I</given-names></name>, <name><surname>Maci&#x000e0;</surname><given-names>F</given-names></name>, <name><surname>Duarte</surname><given-names>E</given-names></name>, <name><surname>Belmonte</surname><given-names>R</given-names></name>. <article-title>Lymphedema Predictor Factors Factors after BC Surgery: A Survival Analysis</article-title>. <source>Lymphat Res Biol</source>. <year>2014</year>; <volume>16</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/lrb.2013.0042">10.1089/lrb.2013.0042</ext-link></comment>
<pub-id pub-id-type="pmid">24837643</pub-id></mixed-citation></ref><ref id="pone.0189176.ref053"><label>53</label><mixed-citation publication-type="journal"><name><surname>Cintolesi</surname><given-names>V</given-names></name>, <name><surname>Stanton</surname><given-names>AWB</given-names></name>, <name><surname>Bains</surname><given-names>SK</given-names></name>, <name><surname>Cousins</surname><given-names>E</given-names></name>, <name><surname>Peters</surname><given-names>AM</given-names></name>, <name><surname>Purushotham</surname><given-names>AD</given-names></name>, <etal>et al</etal>
<article-title>Constitutively Enhanced Lymphatic Pumping in the Upper Limbs of Women Who Later Develop Breast Cancer-Related Lymphedema</article-title>. <source>Lymphatic Research and Biology</source>. <year>2016</year>; <volume>14</volume>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1089/lrb.2016.0005">10.1089/lrb.2016.0005</ext-link></comment>
<pub-id pub-id-type="pmid">27309032</pub-id></mixed-citation></ref><ref id="pone.0189176.ref054"><label>54</label><mixed-citation publication-type="journal"><name><surname>Bae</surname><given-names>H</given-names></name>, <name><surname>Kim</surname><given-names>HJ</given-names></name>. <article-title>Clinical Outcomes of Extracorporeal Shock Wave Therapy in Patients With Secondary Lymphedema: A Pilot Study</article-title>. <source>Ann Rehabil Med</source>
<year>2013</year>;<volume>37</volume>(<issue>2</issue>):<fpage>229</fpage>&#x02013;<lpage>234</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5535/arm.2013.37.2.229">10.5535/arm.2013.37.2.229</ext-link></comment>
<pub-id pub-id-type="pmid">23705118</pub-id></mixed-citation></ref><ref id="pone.0189176.ref055"><label>55</label><mixed-citation publication-type="journal"><name><surname>Taradaj</surname><given-names>J</given-names></name>, <name><surname>Halski</surname><given-names>T</given-names></name>, <name><surname>Rosinczuk</surname><given-names>J</given-names></name>, <name><surname>Dymarek</surname><given-names>R</given-names></name>, <name><surname>Laurowski</surname><given-names>A</given-names></name>, <name><surname>Smykla</surname><given-names>A</given-names></name>. <article-title>The influence of Kinesiology Taping on the volume of lymphoedema and manual dexterity of the upper limb in women after breast cancer treatment</article-title>. <source>European Journal of Cancer Care</source>
<year>2016</year>; <volume>25</volume>: <fpage>647</fpage>&#x02013;<lpage>660</lpage>
<comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/ecc.12331">10.1111/ecc.12331</ext-link></comment>
<pub-id pub-id-type="pmid">25963332</pub-id></mixed-citation></ref><ref id="pone.0189176.ref056"><label>56</label><mixed-citation publication-type="journal"><name><surname>E Lima</surname><given-names>MT</given-names></name>, <name><surname>E Lima</surname><given-names>JG</given-names></name>, <name><surname>de Andrade</surname><given-names>MF</given-names></name>, <name><surname>Bergmann</surname><given-names>A</given-names></name>. <article-title>Low-level laser therapy in secondary lymphedema after breast cancer: systematic review</article-title>. <source>Lasers Med Sci</source>. <year>2014</year>; <volume>29</volume>(<issue>3</issue>):<fpage>1289</fpage>&#x02013;<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10103-012-1240-y">10.1007/s10103-012-1240-y</ext-link></comment>
<pub-id pub-id-type="pmid">23192573</pub-id></mixed-citation></ref></ref-list></back></article>